National Library of MedicineFinding Aid to the Robert M. Chanock Papers, 1933-2008 (bulk 1950-2008)History of Medicine Division
Processed by Jim Labosier
Encoded by Jim Labosier
Processing completed July 2018
Summary Information
Robert M. Chanock Papers
Chanock, Robert M.
1933-2008 (bulk 1950-2008)
87.5 linear feet (70 boxes)
Correspondence, research reports and data, reprints, lectures, and conference notes document Dr. Robert M. Chanock's career studying and developing therapies for respiratory viruses that are particularly common in children, notably human respiratory syncytial virus (RSV) and the para-influenza viruses.
MS C 628
Collection materials primarily in
English
Materials stored onsite. History of Medicine Division. National Library of Medicine
Collection is restricted. Portions of the collection are restricted according to HMD's Access to Health Information of Individuals policy. Contact the Reference Staff for information regarding access. For access to the policy and application form, please visit https://www.nlm.nih.gov/hmd/manuscripts/phi.pdf.
Donor's copyrights were transferred to the public domain. Archival collections often contain mixed copyrights; while NLM is the owner of the physical items, permission to examine collection materials is not an authorization to publish. These materials are made available for use in research, teaching, and private study. It is the user's responsibility to research and understand any applicable copyright and re-publication rights not allowed by fair use. NLM does not grant permissions to publish.
Archives and manuscript collections may contain materials with sensitive or confidential information that is protected under federal or state right to privacy laws and regulations. Researchers are advised that the disclosure of certain information pertaining to identifiable living individuals represented in any collection without the consent of those individuals may have legal ramifications for which the National Library of Medicine assumes no responsibility.
Chanock, Robert M. Robert M. Chanock Papers. 1933-2008 (bulk 1950-2008). Located in: Archives and Modern Manuscripts Collection,
History of Medicine Division, National Library of Medicine, Bethesda, MD; MS C 628.
The Robert Chanock Papers were rehoused from their original containers into archival containers after initial receipt from the donor. In the course of final processing several categories of material were weeded from the original accession and discarded by the processing archivist: books and reprints about viral research not authored by Chanock (books also reviewed for retention by Rare Books staff); personally identifiable information in the form of personnel records, performance reviews, and letters of recommendation relating to employees supervised by Chanock; files relating to Chanock's personal finances. Archivists augmented the original collection by conducting an Archive-It web crawl of selected websites.
Gift, Stephen Chanock, February 15, 2011, Acc. 2011-009; Transfer, Jeffrey Cohen/NIAID, June 17, 2011, Acc. 2011-024.
101574531Finding Aid to the Robert M. Chanock Papers, 1933-2008 (bulk 1950-2008)Archives and Modern Manuscripts Program, History of Medicine Division1.0History of Medicine Division, National Library of Medicine.8600 Rockville Pike
Bethesda, Maryland, 20894
USA
Phone: (301) 402-8878 (Reference Desk)
Fax: (301) 402-0872
Email: hmdref@nlm.nih.gov
Machine-readable finding aid encoded by Jim LabosierFinding aid is written in EnglishNational Library of MedicineFinding Aid to the Robert M. Chanock Papers, 1933-2008 (bulk 1950-2008)History of Medicine Division
Processed by Jim Labosier
Encoded by Jim Labosier
Processing completed July 2018
Descriptive SummaryChanock, Robert M.Robert M. Chanock Papers 1933-2008 (bulk 1950-2008)87.5 linear feet (70 boxes)MS C 628Materials stored onsite. History of Medicine Division. National Library of Medicine
Collection materials primarily in
EnglishCorrespondence, research reports and data, reprints, lectures, and conference notes document Dr. Robert M. Chanock's career studying and developing therapies for respiratory viruses that are particularly common in children, notably human respiratory syncytial virus (RSV) and the para-influenza viruses.Gift, Stephen Chanock, February 15, 2011, Acc. 2011-009; Transfer, Jeffrey Cohen/NIAID, June 17, 2011, Acc. 2011-024.
Collection is restricted. Portions of the collection are restricted according to HMD's Access to Health Information of Individuals policy. Contact the Reference Staff for information regarding access. For access to the policy and application form, please visit https://www.nlm.nih.gov/hmd/manuscripts/phi.pdf.
Donor's copyrights were transferred to the public domain. Archival collections often contain mixed copyrights; while NLM is the owner of the physical items, permission to examine collection materials is not an authorization to publish. These materials are made available for use in research, teaching, and private study. It is the user's responsibility to research and understand any applicable copyright and re-publication rights not allowed by fair use. NLM does not grant permissions to publish.
Archives and manuscript collections may contain materials with sensitive or confidential information that is protected under federal or state right to privacy laws and regulations. Researchers are advised that the disclosure of certain information pertaining to identifiable living individuals represented in any collection without the consent of those individuals may have legal ramifications for which the National Library of Medicine assumes no responsibility.
Chanock, Robert M. Robert M. Chanock Papers. 1933-2008 (bulk 1950-2008). Located in: Archives and Modern Manuscripts Collection,
History of Medicine Division, National Library of Medicine, Bethesda, MD; MS C 628.
The Robert Chanock Papers were rehoused from their original containers into archival containers after initial receipt from the donor. In the course of final processing several categories of material were weeded from the original accession and discarded by the processing archivist: books and reprints about viral research not authored by Chanock (books also reviewed for retention by Rare Books staff); personally identifiable information in the form of personnel records, performance reviews, and letters of recommendation relating to employees supervised by Chanock; files relating to Chanock's personal finances. Archivists augmented the original collection by conducting an Archive-It web crawl of selected websites.
Biographical NoteRobert M. Chanock (1924-2010) was an influential pediatrician and virologist. He served as head of the National Institute of Allergy and Infectious Disease's (NIAID) Laboratory of Infectious Diseases (LID) from 1968 to 2001. He is best known for making major contributions to the prevention and treatment of childhood respiratory infections. Chanock was an internationally renowned virologist who identified a baffling pathogen that infects the majority of infants and is the most common cause of life-threatening pneumonia in premature babies; the first to identify and characterize this pathogen, which he called human respiratory syncytial virus, or RSV. During his six-decade career at NIAID Chanock performed wide-ranging and groundbreaking research on a number of stubborn and dangerous diseases, particularly those affecting children and babies. He was equally admired by colleagues for his ability to foster a dynamic and creative environment in which other scientists also thrived. Members of his lab group identified Norovirus (Norwalk virus), which causes intestinal flu, and developed the first nasal spray flu vaccine. He led research into adenovirus, hepatitis A, rotavirus, West Nile virus, and dengue fever. His team developed vaccines for Hepatitis A, rotavirus, and West Nile virus as well as the first nasal spray flu vaccine. Chanock holds several patents for these inventions and many others.
Chanock was born and grew up in Chicago. Drafted into the Army in 1943 and given a choice to deploy overseas or go to medical school, he chose school and was accepted into the University of Chicago undegraduate school and its School of Medicine, receiving degrees in 1945 and 1947. After interning at Highland Hospital in Oakland, Ca., he returned to Chicago for training in pediatrics. In 1950 while on a fellowship at Cincinnati Children's Hospital, he began working with his mentor and professional inspiration, Dr. Albert Sabin.
Chanock was drafted again in 1952 during the Korean War and was sent to Korea to deal with an outbreak of Japanese encephalitis, also known as Japanese B virus. Chanock never completed this work after suffering a burst appendix; instead he turned to researching infectious diseases while stationed in Tokyo for the remainder of his Korean War service. Upon his return to civilian life, Dr. Chanock studied little-understood viruses which commonly plagued infants. His research took him back to Cincinnati Children's Hospital and Johns Hopkins University before he joined NIAID at NIH. In 1957 he discovered the human respiratory syncytial virus (RSV), which causes respiratory infections in infants. This breakthrough was followed by the determination of four related agents, called para-influenza viruses.
In 1962 Dr. Chanock demonstrated that atypical or walking pneumonia was caused by the bacterium mycoplasma pneumoniae and that it could be cured with antibiotics. His lab developed vaccines to prevent adenovirus infection, Hepatitis A, and rotavirus, the most common cause of severe diarrhoea in infants and young children, and importantly the first nasal spray flu virus vaccine for use with children.
Dr. Chanock is considered an important and influential virologist. He became a member of the National Academy of Sciences in 1973 and is the recipient of the Robert Koch Prize, the Albert B. Sabin Gold Medal, the E. Mead Johnson Award, the Public Health Service’s Meritorious Service Medal, the Distinguished Service Medal, and the Gorgas Medal. Chanock died at age 86 on July 30, 2010.
Correspondence, lab notebooks, research reports and data, reprints, lectures, and conference notes document Dr. Robert M. Chanock's professional research career at NIAID's Laboratory of Infectious Disease studying and developing therapies for respiratory viruses that are particularly common in children, notably human respiratory syncytial virus (RSV) and the para-influenza viruses. Research strengths include a nearly comphrehnsive set of lab notebooks documenting the lab's work on Respiratory Syncytial Virus (RSV) and Paramyxoviridae infections and the business of collaborating with various pharmaceutical companies to produce vaccines.
Series 1, Personal and Biographical (1933-2008), includes correspondence (1950-1957) from research positions Dr. Chanock held before joining NIAID, at the University of Cincinnati and Johns Hopkins, and in the Army in Korea. Dr. Chanock's personal and family life are reflected in correspondence and congratulatory exchanges from colleagues (1933-2008) along with photographs (c.1950s-2005), oral history transcripts (2001-2003), and certificates and awards (1964-2008).
Series 2: NIH-NIAID-Laboratory of Infectious Diseases (LID) (1955-2008) contains incomplete sets of NIAID annual reports (1967-1983), LID annual reports (1966-1997), and LID Board of Scientific Counselor's Reviews (1978-2004). Correspondence (1955-2008) exists in varied orientations: a group arranged alphabetically by correspondent surname spans 1957 to 1979; chronological files are incomplete from 1968 to 1995 and are augmented by informally collected "chronological" files dated 1957-2008; there are also files, arranged alphabetically, by subject (1955-2007). Completing the series is a group of 35mm slide presentations (1961-2005), arranged chronologically, on LID research topics such as mycoplasma and respiratory syncytial virus.
Series 3, Research (1951-2008) is the largest portion of the collection and has many sections. Lab notebooks (1958-2000) are probably the most comprehensive and valuable part of this series. Arranged by surname of the LID researcher, they provide a day to day picture of research being conducted in the lab. The work of Dr. Chanock, Albert Kapikian, and Wallace P. Rowe are documented here, along with nine other researchers. A smaller set of lab notebooks designated by subject title, such as neuroaminidase, is arranged alphabetically. Research data, (1950-2008), is the least well described part of this series. Often these chronologically arranged folders bear brief titles, leaving only the material's date and context to aid in determining more specifically what studies they may pertain to. Cooperative Research and Development Agreements (CRADA) (1972-2003) with several pharmaceutical companies, notably Lederle and Wyeth, are arranged alphabetically by company name. Research contract reports range in date from 1952 to 1998. All of them after 1957 are contracts with NIAID. Most are arranged by contract number, the bulk of whose numbers are prefaced by "N01" or "PH". Proposals for research contracts which don't correspond to known contracts (1955-2001) are arranged chronologically. Investigational New Drugs (IND) reports (1963-2001) record results, in the form of supplements, of experimental drug testing by NIAID in collaboration with pharmaceutical companies. These are arranged by the Food and Drug Administration's assigned IND number. LID lab research reports (1960-2004) concern only documentation of studies undertaken in the NIAID lab without collaborators. These are arranged chronologically except in the few exceptions when contract numbers are evident.
Series 4, Patents (1966-2008) which Dr. Chanock co-invented, is arranged numerically by patent number. Related to each is material often in several folders documenting the patent submission and approval process, licensing to pharmaceutical companies, and applications for corresponding foreign patents.
Series 5, Writings/Reprints (1953-2007) contains an incomplete set of Dr. Chanock's scientific articles, which in their entirety total 653 (1953-2003). Smaller subsections of this series hold eight articles by Dr. Chanock which are not represented on his bibliography (1954-2007); drafts of articles not corresponding with his published work (c.1960s-c.2007); and untitled drafts and writing fragments (c.1955-c.2007). Reprints are arranged by number assigned in Dr. Chanock's bibliography. The other sections are chronological.
Series 6, Meetings (1954-2005) contains programs, proceedings, notes, and other related information collected by Dr. Chanock when he attended national and international health conferences focusing on virology. He regularly attended meetings held by the American Society for Clinical Investigation, World Health Organization, American Epidemiological Society, and American Society for Microbiology. The series is arranged chronologically.
Series 7, Lectures and Speeches (1951-2005) are arranged chronologically. While a number of the earlier speeches lack identification as to where or when they were delivered, most after 1970 were lectures given at conferences or on honorary occasions.
Series 8, Videocassettes (1985-1987) mostly cover two subjects: the February 12, 1985 Wallace P. Rowe Symposium, and the August 26, 1986 Scientific Symposium in Honor of Albert B. Sabin's 80th Birthday.
These terms are indexed in the National Library of Medicine's online catalog LocatorPlus. Researchers wishing to find related materials should search the catalog using these terms.
- Antibodies, Bacterial
- Bacterial Vaccines
- Immunotherapy
- Paramyxoviridae Infections
- Respiratory Syncytial Virus Vaccines
- Vaccines, Attenuated
- Viral Vaccines
- Virology
- Rowe, Wallace, -1983
- Sabin, Albert B. (Albert Bruce), 1906-1993
- Children's Hospital (Cincinnati, Ohio)
- National Institute of Allergy and Infectious Diseases. Laboratory of Infectious Diseases Branch
Series Descriptions
Series 1: Personal and Biographical,
1933-200811
Biographical sketches,
1993-199812
Scrapbook,
1950-197313-6
CVs and bibliography,
1987-200417
High school essays,
1940-194118
University of Chicago - correspondence,
1942-194919
University of Chicago Medical and Biological Sciences Alumni Association - reunion class of 1947 - dinner menu and yearbook,
1997110-12
University of Chicago - course notes, lab procedures, dietary formulations,
1948-1950691
Sydenham Hospital patient records,
1948[RESTRICTED PHI POLICY]
113
Medical license,
1976-1994114
Army discharge,
1946115-22
U.S. Army service in Korea - correspondence, orders, data,
1949-1955693
U.S. Army - Korea - Q fever and scrub typhus,
1953[RESTRICTED PHI POLICY]
123-26
University of Cincinnati College of Medicine fellow - correspondence, reports,
1950-1952127
Children's Hospital Research Foundation - correspondence,
1955-1956694
University of Cincinnati College of Medicine,
1955[RESTRICTED PHI POLICY]
128-30
Johns Hopkins - correspondence, laboratory manual, notes,
1956-1957131-34
PHS Commissioned Officer - orders, correspondence, identification, retirement,
1957-1988135-37
National Institute of Allergies and Infectious Diseases Oral History Interview - conducted by Peggy Dillon,
2001-2003138
Retirement guestbook,
c.2008
Family Correspondence,
1933-1995139
From Robert to his family,
1933140
From Robert to Beth Chanock,
1948-1955141
Notes,
c.1950s142
Well wishes on pericarditis,
196721
Family and friends,
1968-199522
Congratulations on birth of grandson,
198323
Chanock, Foster Osgood,
1975-198024
Chanock, Frances E.,
199525
Chanock, Stephen J.,
1971-1989
Awards and Honors,
1945-200826
Various certificates,
1945-200827
E. Mead Johnson Award for Research in Pediatrics - congratulations and correspondence,
27 October 196428
Kimble Methodology Award - letters of congratulations and correspondence,
31 October 196629
Infectious Diseases Society of America Squibb Award - congratulations, correspondence, and acceptance speech,
25 October 1969210
DHEW Distinguished Service Medal - correspondence, photographs, and ceremony program,
15 April 1971211
Gorgas Medal - announcement and clipping,
11 December 1972212
Election to National Academy of Sciences - letters of congratulations,
1973213
Howard Taylor Ricketts Award - announcement, congratulations, event program, lecture transcript,
14 May 1973214
Award for Distinguished Achievement - announcement,
1976215
University of Chicago - honorary doctorate - announcement, photographs, and convocation program,
14 November 1977216-17
Robert Koch Stiftung Award - correspondence, letters of congratulations, ceremony program, photographs, lecture transcript,
7 December 1981218-23
ICN International Prize in Virology - announcement, correspondence, letters of congratulations, ceremony program, photographs,
7 February 1991224
Presidential Meritorious Executive Rank Award,
1993225-26
Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Disease Research - announcement, letters of congratulations, ceremony program, and clippings,
7 December 1993227
Albert B. Sabin Gold Medal Award - letters of congratulations, ceremony program, lecture transcript, and clippings,
14 September 1995228
American College of Physicians Award for Outstanding Work in Science as Related to Medicine - correspondence,
May 2008
Photographs,
c.1950s-2005229
Aboard the 'Independence',
c.1950s230
Dr. Chanock's friends and colleagues,
c.1960s-2000s231-33
Dr. Chanock - with family, in groups, in PHS uniform, at conferences, in laboratory,
1988-1998, undated234
A celebration of the career of Dr. Robert M. Chanock, Laboratory of Infectious Diseases, NIAID, NIH,
21 October 2005
Clippings,
1954-2008235-37
General,
1958-200831
Obituaries of colleagues,
1995-199832
re Influenza,
1947-199833
Virus discoveries,
1954-1980Born Digital
Archive-It web archive, top results for "Robert Chanock" Google search conducted by HMD staff, 2018[view online]
Series 2: NIH-NIAID-Laboratory of Infectious Diseases (LID),
1955-200834-14
NIAID Annual Reports,
1967-197241-14
NIAID Annual Reports (cont'd),
1973-198051-5
NIAID Annual Reports (cont'd),
1980-198356-13
LID Board of Scientific Counselors Review,
1978, 1981, 1984, 1987, 1992, 199661-11
LID Board of Scientific Counselors Review (cont'd),
1996, 2000, 2003, 2004612-23
LID Annual Reports [3.5 computer disks],
1966-1970; 1972-1973, 1976, 1982, 1984, 1985, 198771-14
LID Annual Reports (cont'd),
1987-199681-2
LID Annual Reports (cont'd),
1996-199783-35
Calendar - Dr. Chanock's,
1971-2006
Correspondence,
1955-2008836-50
Alphabetical by correspondent - A-H,
1957-196891-19
Alphabetical by correspondent - H-W,
1957-1968920-25
Alphabetical by correspondent - A-L,
1969-1975101-6
Alphabetical by correspondent - M-Z,
1969-1975107-24
Alphabetical by correspondent - A-T,
1975-19961025-27
Alphabetical by correspondent - A-Z,
1978-19791028
Becker, Walter B.,
1963-19711029
Brown, Fred,
1989-19921030
Children's Hospital, Philadelphia - Dr. Lief,
1964-19661031
Croup agent,
1955-19581032
Fenner, Frank,
1978-19971033
Roizman, Bernard,
1974-19881034
Siim, J. Christian,
1979-19911035
Stuart-Harris, Charles,
1977-19831036
Syrucek, Lubomir,
1965-19721037
Walter Reed Army Medical Center,
1962-19691038
Wyeth Laboratories,
1964-19691039-41
Chronological Files,
1968, 1971-1972111-21
Chronological Files,
1973-1981, 1984-1986, 1989-1993, 19951122-44
Chronological miscellaneous correspondence,
undated, 1957-1980121-28
Chronological miscellaneous correspondence (cont'd),
1981-2008
Correspondence of Harry Greenberg and Anthony Kalica,
1976-19831229
Greenberg, Harry correspondence - A-Z by correspondent name,
1976-19831230
Kalica, Anthony correspondence - A-Z by correspondent name,
1976-1982131
Kalica, Anthony correspondence - A-Z by correspondent name (cont'd),
1976-1982
Subjects,
1955-2007132-5
1918 Flu 2005 Avian Flu,
2002-2006136
4 New Breast Cancer Genes / DNA Variations for 7 Diseases,
2007137-8
Acambis,
1999-2007139
Adenovirus and AAV,
1964-20011310
Adjuvants for influenza virus vaccines, including use for H5N1 if needed,
20061311
Agracetus [photocopy of 1947 article],
undated1312-13
Albert B. Sabin Vaccine Foundation, Inc.,
1991-19941314-15
Anthrax,
1999-20041316
Anthrax incidents, hoaxes and threats,
19991317
Armed Forces Epidemiological Board (AFEB) - 50th year anniversary,
28 June 19901318-19
AFEB Commission on Acute Respiratory Diseases - annual reports,
1969, 20011320
AFEB Commission on Influenza - annual report,
19711321
Australian National University - annual reports,
1961-19671322-23
Avian flu,
2002-20071324
Biodefense NIAID,
20021325
Bioshield 5105,
20051326
Bioterrorist activities - Peter Jahrling, Ph.D. [35mm slides],
29 January 19991327
Biowarfare,
1988-19941328
Byrne, Robert J., D.V.M. - Deputy Director, Experimental Applications Branch, NIAID,
1979-19801329
Chiefs of NIAID [photographs],
2001141
Choppin, Purnell,
c.1985142
Cold Spring Harbor correspondence,
1986143
Conflict of interest issues,
2005144
Consultancies - Molecular Vaccines, Inc., and Medimmune,
1988-2002145
Dangers of mutants,
1977146
Dengue - Jo Blaney,
28 November 2007147
Dengue vaccine,
c.1989148
Inter-Divisional Vaccine Working Group,
17 September 1993149
Edelman memos and correspondence,
1976-19881410
Ethics - L.A. Times,
September-October 20041411
Executive office NIAID,
1985-19881412
Fauci, Dr. Anthony - Director NIAID,
1985-19871413-15
Food and Drug Administration (FDA) - Panel on Review of Viral Vaccines and Rickettsial Vaccines,
19751416
Freezer repository - inventory contents,
19921417
Gallin, Dr. John - Director, Intramural Research Program, NIAID,
1985-1988
Goldberg II
Articles sent to Dr. Chanock by journalist Billie Goldberg organized thematically.
1418
Antivirals,
20051419
Cancer,
20051420
Dengue,
20051421
DNA vaccines,
20051422
Ebola and Marburg vaccines,
20051423
HIV SIV,
20051424
Human melanoma virus,
20051425
Immunology,
20051426
Nobel,
20051427
RNAi,
20051428
Shingles,
20051429
Aviflu,
20061430
Biodefense tick borne encephalitis virus,
20061431
HIV vaccine,
20061432
Important role of inflammation in cardiovascular disease,
20061433
Kaposi sarcoma virus receptor,
20061434
Old viruses resurrected inhuman DNA,
20061435
Osteoporosis protein diabetes genes,
20061436
Polio-Weimmer,
20061437
Prostate cancer Rx therapy,
20061438
RNAi clinical,
20061439
Max Theiler 1951,
20061440
Vertex HCV,
20061441
Vioxx Merck,
20061442
West Nile transplant patients,
20061443-44
Hartley, Janet,
1981-19941445
House hearings on influenza vaccine,
August 19721446
Huebner, Robert,
1969-2002151
Huebner, Robert (cont'd),
1969-2002152
Huebner celebration,
11 November 1999153
Hybridon - contract and approval,
1994-1996154
ICN Pharmaceuticals,
1990-1991155
Infectious Disease Society of America,
1990156
Infu H5N1 DOD/NIAID,
2006-2007157
Interpretation of serologic reactions in virology - DHEW,
c.1965158-9
Intracel,
2000-20011510
Intramural Research Program,
1985-19871511
Johns Hopkins Society of Scholars,
19991512
Kapikian, Albert Z. [photographs],
19841513
Krause, Richard M. - Director, NIAID,
1979-19811514
Krause, Richard M. (cont'd),
24 March 19951515
Laboratory methods in the diagnosis of viral exanthems - DHEW,
c.19651516
Laboratory of Viral Diseases - annual report,
19691517
Laboratory of Infectious Diseases - history [35mm slides],
19921518
Laboratory techniques in virology - DHEW,
c.19651519
Mattheis, Martha - Infectious Disease Branch,
1979-1984
MedImmune1520
General,
1998-20051521-25
General (cont'd),
1998-20051526
Adverse publicity,
19981527
Biological materials license agreement,
19961528-38
Meetings,
1989-2002161-4
Meetings (cont'd),
1989-2002165
Sales of Synagis,
January-March 2000166
Molecular Vaccines, Inc.,
1988-1989167
Monoclonal abs, RSV and otherwise,
1990-1994168-14
Morris, Anthony,
1973-19781615-16
Mycoplasma pneumonia and others,
1961-20021617-27
National Academy of Sciences - Committee on International Security and Arms Control (CISAC),
1988-1997171-8
National Academy of Sciences - Committee on International Security and Arms Control (CISAC) (cont'd),
1988-1997179
National Academy of Sciences - Sabin, memoirs Rowe,
19981710
National Cancer Institute - Frederick Cancer Research Facility Advisory Committee - meeting,
13 February 19871711
NIAID Animal Care Committee,
1973-19801712
NIAID Biodefense Research Agenda for Category B and C Priority Pathogens - progress report,
20041713-14
NIAID Blue Ribbon Panel on Terrorism and its Implications for Biomedical Research,
20021715-16
NIAID Clinical Research Subpanel,
1969-1980181
NIAID Clinical Research Subpanel (cont'd)182
NIAID Committee for Vaccine Development - correspondence,
1962-1967183
NIAID Extramural Activities - report,
1968184-6
NIAID Intramural Research Program - reports,
1968-1972187
NIAID Laboratory Chiefs - meeting minutes,
2002-2005188
NIAID Laboratory of Biology of Viruses - annual report,
1968189
New York City Department of Health - laboratory analysis of 1957-1958 influenza outbreak in New York City,
19591810-11
Pandemic avian flu - Secretary Leavitto's response for greater vaccine production from pharmaceutical manufacturers,
20061812
Pandemic flu preparedness,
20011813
Papilloma viruses,
c.20001814-15
Parainfluenza virus,
19981816
Parainfluenza virus / glioma,
2004-20051817
Pletnev 5 yr plan,
20041818
Pneumonia,
19791819
RSV and PIV3 high risk persons: RSV LID,
1991-19921820-21
RSV pathogenesis acute and COPD (II),
19931822-26
Rowe and Huebner [photographs],
1982-19981827
Royal Danish academy of Sciences and letters - elected as foreign member,
19801828-29
Russian TBEV collaboration,
20021830-33
Sabin, Dr. Albert [photographs],
1964-2006191-7
Sabin, Dr. Albert (cont'd),
1964-2006198
Sabin poliovaccine [35mm slides],
c.1986199
Sabin poliovirus vaccine clinical field trials - final report,
19611910
Sabin/Schlesinger dengue,
20031911
Scripps Research Institute,
1987-19961912
Seasonal and pandemic influenza,
20071913
Sell, Kenneth W. - Scientific Director, NIAID,
1978-19841914
Small pox,
2001-20061915
Smorodintsev adenovirus vaccine,
19691916
Society for Pediatric Research,
19931917
Sugata, Fumihiko,
19931918
Synagis,
1999-20011919
Synergistic effect when two disparate mabs are used,
2002-20061920
Tyrrell, D. A., Jr.,
1970-19911921
U.S. Public Health Service - technical report on Salk poliomyelitis vaccine,
19551922
University of British Columbia, Dept. of Microbiology, Div. of Medical Microbiology - annual report,
19711923
University of Maryland - prison studies hearing,
3 September 1975
Vaccine,
1958-20061924
Adenovirus vaccine program - business case analysis,
c.20061925
Vaccine development at the Laboratory of Infectious Diseases,
c.20001926
Current status of vaccines for prevention of respiratory syncytial virus infection in infants and children - Peter Wright,
20031927
Licensed viral vaccines (U.S.A.),
19881928-29
Rotavirus vaccines,
2000-20061930
Virology Section - report,
19701931
West Nile and Dengue,
20031932
World Health Organization (WHO) - viral disease reports,
1958-19711933
WHO Expert Advisory Panel on Virus Diseases,
1997
Presentations on 35mm Slides,
1961-20051934
Influenza Dearborn TS1[E],
undated1935
Influenza TS1,
undated1936-40
Mycoplasma,
undated201-2
PI Mpn epidem.,
undated203
Poly IC study Knopp,
undated204
Respiratory Syncitial,
undated205
Respiratory Syncitial Coates,
undated206
Smith and Chanock Eaton vol,
undated207
Mycoplasma,
1961208
Pneumonia,
1961209
Respiratory Syncytial Mpn,
19612010
Adeno caps PI,
19642011-12
Mycoplasma,
c.19652013
Respiratory Syncytial and Para,
c.19662014
IOM priorities and Respiratory Syncytial Virus,
19662015
Mycoplasma,
c.19672016
Mycoplasma Boston,
19672017
Importance viruses and Mpn respiratory disease,
19682018
Respiratory Syncytial temperature sensitive,
19682019
Mycoplasma,
19692020
Mycoplasma pneumoniae ASM,
19702021
Mycoplasma, pneumonia, pap,
19702022
PAHO,
December 19702023
Flu (temperature sensitive),
19712024
Mycoplasma,
19712025
Respiratory Syncytial Virus,
19712026
Mycoplasma NY Acad.,
January 19732027
Respiratory Syncytial,
19732028
Animal rights,
c.19792029
Rotavirus, dengue, vaccines, etc.,
1980-19812030
Long-term goals and strategy of LID research / Sabin polio vaccine,
1986-19882031
RSV, dengue, etc.,
c.19892032
Respiratory Syncytial,
19892033
Respiratory Syncytial Virus chimps and Respiratory Syncytial Virus summaries,
19902034
Respiratory Syncytial Virus vaccines,
19902035
Rotavirus,
19902036
Respiratory Syncytial Virus mabs and fabs,
1990-19952037
Respiratory Syncytial Virus,
19912038
Respiratory Syncytial Virus,
1992-19932039
Respiratory Syncytial Virus (cont'd),
1992-19932040
St. Lucia - history of respiratory,
December 20002041
Parainfluenza viruses as vectors for the protective antigens of RSV and other respiratory viral antigens,
20042042
Reverse genetic studies of the HMPV glycoproteins; Coronavirus vaccines; Respiratory syncytial virus vaccine development,
2005
Series 3: Lab Research,
1951-2008
Lab Notebooks by researcher,
1958-2000211-2
Abinanti, Francis R.,
1958-1964213-19
Chanock, Robert M.,
1958-2000221-19
Chanock, Robert M. (cont'd),
1958-2000231-19
Chanock, Robert M. (cont'd),
1958-2000241-4
Chanock, Robert M. (cont'd),
1958-2000245-8
Cook, M. Katherine,
1960-1975249
Dans, Peter E.,
1966-19672410
Forsyth, Ben R.,
1965-19662411-18
Hoggan, M. David,
1972-19852419
Johnson, Karl M.,
1959-1962251-3
Johnson, Karl M. (cont'd),
1959-1962254-8
Kapikian, Albert Z.,
1977-1981259-10
Lewis, Marianne,
1972-19842511-17
Mufson, Maurice A.,
1962-19652518-19
Rowe, Wallace P.,
1958-1972261-19
Rowe, Wallace P. (cont'd),
1958-1972271-16
Rowe, Wallace P. (cont'd),
1958-1972
Lab Notebooks by Subject,
1954-19942717
CF Antigens,
1954-19752718
Miscellaneous Virus,
19572719
Neuraminidase,
1974-1993281-8
Neuraminidase (cont'd),
1974-1993289
Radioactive Materials,
1971-19742810-16
Viral Reagents,
1962-1994
Research Data,
1950-20082817-19
Miscellaneous/Unidentified Studies,
undated291-7
Miscellaneous/Unidentified Studies (cont'd),
1950-2005298
Japanese B encephalitis,
1951-1954299
Lab studies on adenovirus, pneumonia or bronchiolites,
1952-19562910
Avian Japanese B encephalitis,
1953-19552911
Transplacental transmission polio virus,
1954-19552912
Polio chick embryo,
19552913
Yale - Monkey kidney trypsinization techniques Ph colon test,
1955-19562914
Experiment 2. Assay of a high titer phage stock relation of plaque count to volume of phage suspension plated,
19562915
Etiology of nonbacterial respiratory disease in infancy and childhood - NIH senior fellowship grant,
19562916
Serology,
1956-1957699
1 RSV collation,
1956-1957[RESTRICTED PHI POLICY]
2917
Croup,
1956-19592918
Pap virus,
1958-19596911
Mycoplasma - U.S. Naval Hospital, Beaufort, S.C. - patient summaries,
1959-1960[RESTRICTED PHI POLICY]
2919
Respiratory viruses and mycoplasmas clinical: Pap study - Parris Island,
1959-19612920
#2 neutralization tests #19,
1959-19982921
Immunization,
1961-19626914-15
RS vaccine study,
1962-1975[RESTRICTED PHI POLICY]
2922
Contribution of adenoviruses to respiratory tract illness among children,
19632923
Evaluation of WI-26 human diploid fibroblast cultures for isolation of adenovirus type 4,
19632924-25
Lots of vaccine - Wyeth,
1963-19682926-27
Mycoplasma,
1963-19922928
Ludwig adeno capsule,
19642929
Respiratory viruses and mycoplasmas clinical: adeno field trials - Parris Island,
1964-1965301
Respiratory viruses and mycoplasmas clinical: m. pneumonia trials - Parris Island,
1965-1966302
Respiratory viruses and mycoplasmas clinical: rs attenuated strain - 2,
1965-19706918
Children's Hospital contract reports,
1965-1981[RESTRICTED PHI POLICY]
303
Drug protocols - Wyeth,
1966304
Respir. Viruses and mycoplasmas clinical: adeno field trials other,
1966-19676917
RS vaccine study,
1967[RESTRICTED PHI POLICY]
305
Experimental rubella vaccine lot 12-6/6A,
1967306
Myxovirus recovery from respiratory tract illness - summary tables,
1967307
Camargo, Ena - RSV - paraflu III plaque,
1967-1972308-13
RS vaccine - Children's Hospital of D.C.,
1967-19793014-16
Production protocol - adenovirus vaccine, life, oral - type 7 - Wyeth,
1968-693020
RS #3 challenge of para 1 new,
November 19703017
RS ts 1 mutant - Jessup,
30 December 19693018
Clinical research protocols,
1969-19783019
RS volunteer - wild type challenge of ts1 vaccinees,
13 February 19703021
DBS-IND-294 Wyeth, adenovirus vaccine, type 7, live, oral - book 2,
1970-19723022
Antibody response to m. pneumoniae vaccine,
19713023
RSV clinical summary - Children's Hospital,
19713024
Virus-associated immunopathology animal models and implications for human diseases,
c.19723025
RSV primates: to RS in children,
c.1972-19736923
Children's Hospital - nasal washings,
1972-1974[RESTRICTED PHI POLICY]
3026
Lab reports,
19733027
Influenza A/1968 (H3N2) virus serum hemagglutination - inhibition antibody status of children before and after the Nov. 1972-Jan. 1973 epidemic of influenza A/1972 (H3N2) in Washington, D.C.,
19733028
Clinical observation of infants/children receiving RS-A2, ts-1 mutant,
19733029
Mycoplasma vaccine trial (OSU-1) - Naval Medical Field Research Laboratory,
19743030
Safety test protocol - A/Georgia/101/74 clone 1B,
19743031
RS vaccine summaries - Children's Hospital,
1974-1975311
RSV primates: bovine RSV in cotton rats, owl monkeys and chimps,
1974-1993312
Swine influenza - Burroughs Wellcome Research Labs,
1975-1979313
Camargo, Ena - RSV,
1975-1980314
Huebner tumorigenicity TS-1-E (Morris),
1976315
Status of two dose trials,
1976316
Safety test - parainfluenza virus type 3, strain #22311 (lot F-367),
1976317
RSV primates: genetic stability - stress tests RS,
1976-1989318
Safety test of influ. A/VIC/3/75 (H3N2) x ts-1 [E], clone 81C1, recomb. virus (code CF/PP/1) - Flow Labs,
1977319
Lot F-486 - RSV, strain A2, TS-1 NG-16 mutant,
1977-19793110
RSV primates II,
1977-19913111
Attenuated influenza vaccines,
19813112
Nasal washings - Children's Hospital,
19813113
RSV hr mutants in primates ts in primates: guinea pig kidney cell grown RSV - pass 18 chimps,
19813114
RSV primates: cotton rat RS,
19813115
RSV hr mutants in primates ts in primates: chick lung cell grown RSV passage 6 - chimps,
19823116
RSV primates,
1982-19933117
Research labs - Merck Sharp and Dohme,
1983-19913118
SV40,
1983-20013119-20
Production protocols - Wyeth,
19853121
RSV hr mutants in primates ts in primates: primates studies RSV,
1986-19903122
Immunization: flavi and alpha viruses,
19883123
Prophylactic effect antibodies,
18 October 19883124
MF59 Chiron,
1989-20063125
RSV vaccine testing,
1989-20063126
Fourth NIH rotavirus vaccine workshop,
5-6 November 19903127
RSV ICN Krugman,
1991-19933128
Flavivirus vaccine research - Walter Reed-NIAID,
1991-19943129-30
RSV human fob monoclones,
December 1991-February 19953131
CA influenza virus - Wyeth,
1992-19933132
RSV - Repligen,
19933133
Fab 19 MARM,
1993-19953134
RSV human FABS,
5 February 19953135-36
AGMK cells, karyotype, tumor tests, patent,
1994-2000321-3
Bovine RV (4x) clinical trial,
1997324
U.S.-Russian collaboration final report,
1997325-7
TBEV LGT,
1998-2000328-9
TBEV II and West Nile,
20003210
History of discovery and development of successful interventions,
20003211
West Nile virus,
2000-20063212
Periodic dengue, West Nile, TBEV meetings,
20013213-14
Dengue vaccine part II,
2001-20073313
Dengue virus and West Nile virus,
20083215
Dengue virus vaccine development,
2002331
TBEV and Langat II,
2002332
Dengue virus vaccine data,
2003333
Restoration of live adenoviruses vaccine in DOD,
2003-2005334-6
Negative SV40,
2004337-8
Positive SV40,
2004339
Dengue virus vaccine development,
20043310
Clinical WN/Den4 serology immunogenicity - clinical Lat/Den4 serology immunogenicity,
20053311
Dengue candidates,
August 20063312
Den langat,
2006
LID Lab Research Reports,
1960-20043314-27
Clinical research projects,
1960-19823328
NIAID ad hoc contract review,
19733329
Experimental immunoprophylaxis against respiratory syncytial virus infections in primates,
undated3330
Experimental infection of primates with respiratory syncytial virus,
undated3331
Histological and virological study of the neurovirulence in rhesus monkeys of a langat/dengue 4 chimeric virus and its parental strains langat virus and dengue type 4 virus,
undated3332
Virological analyses of recombinant, live, attenuated respiratory syncytial virus subgroup A strain rA2cp248/404/1030ΔSH in healthy unscreened 4-12 weeks old infants,
undated3333
RNA tumor viruses as etiologic agents of solid tumors as well as leukemia - NIAID/NCI collaborative research,
19683334
Determination of the effect of an inducer of interferon (IN-CN) administered to upper respiratory tract on experimentally induced respiratory virus infections,
19693335
Safety of cold adapted respiratory syncytial virus vaccine in infants 6-7 months of age,
19693336
Serum complement in acute bronchiolitis,
19693337
Pediatric adenovirus vaccine evaluations,
19713338
Fort Detrick reports,
1972-1977341
Chanock scientific studies,
1973-1992342
Transferring viruses to NIAID,
1997-1998343
Development of a rotavirus vaccine for the prevention of severe rotavirus diarrhea of infants and young children - LID Epidemiology section,
c.2000344-5
Development of new approaches for vaccines against the tick-borne encephalitis virus complex - Molecular Viral Biology section,
2000-2001346
Phase I study of Ad4-ΔE3-HIVenv and Ad4-ΔE3-HIV/gag/pro recombinant vaccines in HIV-negative volunteers,
2001347
Projected schedule for WNV/DEN4 chimera studies,
2001348
New molecular approaches to develop live attenuated vaccines against the tick-borne encephalitis complex and the West Nile encephalitis virus,
2003349
The development of vaccines for parainfluenza virus types 1, 2, and 3 - Respiratory Viruses section,
20043410
In vitro models of paramyxovirus infection,
20043411
New molecular approaches to develop live attenuated vaccines against tick-borne encephalitis virus complex and the West Nile and St. Louis encephalitis viruses - Respiratory Viruses section,
20043412
NIAID 69-A - Study of non-bacterial respiratory disease A) children,
1966-19693413
NIAID 69-B - Non-bacterial respiratory disease in military recruits - epidemiology and experimental immunoprophylaxis,
19663414
NIAID 69-C - The etiology of acute respiratory disease in civilian adults,
19653415
NIAID 69-D - Collaborative studies of biophysical properties of respiratory viruses which are important to the development of vaccines,
19663416
NIAID 70-A - Laboratory studies of newly r4ecognized viruses associated with respiratory illness,
19663417
NIAID 70-B - Characterization of newly discovered rhinovirus serotypes of human origin,
19663418
NIAID 70-C - Basic studies on mycoplasma,
19663419
NIAID 70-C.1 - Serology and seroepidemiology of mycoplasmas (pleuropneumonia-like organisms - PPLO),
19663420
NIAID 70-D - Laboratory studies of viral hepatitis agents,
19663421
NIAID 70-E - Biological and biophysical studies of rhinoviruses,
1966-19693422
NIAID 72-B - Study of respiratory viruses and mycoplasmas in human volunteers,
1969
Investigational New Drugs (IND),
1963-20013423
Unnumbered - Attenuated quadrivalent human-bovine (UK) rotavirus reassortant vaccine - original submission,
19953424
Unnumbered - Wild-type and attenuated respiratory syncytial viruses; subgroup B,
19933425
IND #24 - Parainfluenza type 3 vaccine - suppl. 1-4,
1963-19673426-31
IND #71 - Live adenovirus type 4 enteric vaccine - suppl. 31-50,
1967-19723432-35
IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24,
1964-1973351-2
IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24 (cont'd),
1964-1973353
IND #385 - Monovalent adenovirus type 2 soluble antigen vaccine, aqueous or alum absorbed - suppl. 1, 4-6,
1969-1971354
IND #386 - Live, attenuated rubella virus vaccine strain HPV-79-RK 7, lot 31764 - suppl. 2-3,
1969355
IND #401 - Meningococcal group C vaccine - suppl. 1-36,
1969-1973356-7
IND #419 - Complexed polyinosinic and polycytidylic acids - suppl. 1-13,
1969-1970358-9
IND #421 - Parainfluenza 3 challenge pool (attenuated?) - suppl. 1-23,
1969-19733510
IND #437 - Pneumococcal polysaccharide vaccines,
1970-19723511
IND #450 - Vaccinia virus vaccine -suppl. 7,
19713512
IND #582 - H. Influenzae type b PRP vaccine - suppl. 10, 188,
1972-19873513-20
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399,
1972-1995361-17
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995371-18
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995381-18
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995391-18
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995401-18
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995411-3
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995414-5
IND #734 - TS mutants of mycoplasma pneumoniae - suppl. 1-1C (inactive),
1974-1977416
IND #735 - Inactivated monovalent influenza B virus vaccine,
1973417-8
IND #825 - Inactivated influenza A virus vaccines subunit - suppl. 1-30,
1974-1980419
IND #839 - Poly I; poly C: poly-l-lysine - suppl. 1,
19744110
IND #1044 - Live parainfluenza virus vaccines types 1, 2, and 3, placebo - suppl. 1-8 (inactive),
1975-19784111-19
IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51,
1976-1980421-6
IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51 (cont'd),
1976-1980427
IND #1287 - Adenovirus subunit vaccines - suppl. 1-11,
1978-1982428-17
IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118,
1978-1990431-17
IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118 (cont'd),
1978-19904318
IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37,
1979-1993441-5
IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37 (cont'd),
1979-1993446
IND #1462 - Varicella virus vaccine - suppl. 123,
1987447-20
IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139,
1980-1998451-15
IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139 (cont'd),
1980-19984516
IND #1808 - E. coli CFA/II pili vaccine oral - suppl. 4,
19854517
IND #1914 - Interferons - suppl. 9-10,
19854518
IND #2000 - Vi capsular antigen - suppl. 4,
19854519-21
IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63,
1988-1995461-7
IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63 (cont'd),
1988-1995468-10
IND #2858 - Bovine parainfluenza virus type 3 - suppl. 1-30,
1988-19944611-14
IND #4006 - Rhesus rotavirus vaccines, live, (tetravalent, serotypes 1, 2, 3, and 4) oral - suppl. 1-25,
1988-19984615-19
IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58,
1993-2000471-5
IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58 (cont'd),
1993-2000476-9
IND #4981 - Respiratory syncytial virus subgroup B (strain 14617, vero 1 cells) wild type and attenuated live vaccines - suppl. 1-33,
1993-20004710
IND #7762 - Respiratory syncytial virus, live, attenuated vaccine and purified fusion protein with alum - suppl. 1-6, 8-9,
1998-2001
Research Contracts,
1952-2001
Proposals,
1955-20014711
Unidentified,
undated4712
Etiology of viral diarrheas - part III,
undated4713
To obtain a recombinant form of type 1 poliomyelitis virus capable of multiplication in the embryonated egg,
19554714
Assess antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . .,
c.19644715
The isolation of viruses and viral subunits,
19644716
Respiratory syncytial virus vaccine concentrated 100-fold from monkey kidney tissue cultures,
c.19654717
Studies on adenovirus vaccines,
c.19654718
Biochemical and immunologic investigations of neisseria meningitidis,
19654719
Development of prototype, inactivated vaccines for respiratory syncytial and parainfluenza viruses and for mycoplasma pneumoniae,
19654720
To assess the antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . .,
19654721
Concentration of human hepatitis virus (supplement to NIAID Support of Man program),
19664722
Proposed vaccine studies, Kansas City,
19664723
Respiratory virus vaccines,
19674724
Tests in infants and children for antigenicity and effectiveness of inactivated vaccines,
19674725
X-ray crystal structure of adenovirus coat protein,
19694726
Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children,
19714727
Studies on hemophilus influenzae b vaccine,
c.19724728
Specific cell-mediated immunity to respiratory syncytial virus in infants and children following natural infection or immunization,
19744729
Hybridization of highly radioactive adenovirus DNA strands with cancer DNA to detect viral DNA copies in human cancer cells,
19754730
Evaluation of skin test reactivity during wild type and temperature sensitive influenza virus infection,
19754731
Protective efficacy of langat virus vaccines in mice - animal study proposal,
19974732
Evaluation of protective efficacy of dengue vaccines in mice - animal study proposal,
19994733
Evaluation of chimeric TBEV/DEN4 virus vaccines in mice,
20014734
Immunogenicity and protective efficacy of langat virus vaccines in mice,
2001
Reports,
1952-19984735-39
National Foundation for Infantile Paralysis - Children's Hospital, Cincinnati,
1952-19564740
Vaccine development program commitments,
19654741
Respiratory vaccine development,
19664742
Induced upper respiratory tract infection of man with living adenovirus vaccine type 4, study #1, Lorton Reformatory,
19674743
NIAID Molecular Anatomy Program,
19674744
Evaluation of a live type 4 adenovirus vaccine,
1967-19684745
Acute infectious nonbacterial gastroenteritis,
19734746
103, 1169, 943 - Tissue culture and serology oncogenicity studies, RSV studies,
1964-19654747
6-61-03-032 - Studies on virus and rickettsial diseases,
19534748
263-81-C-0295 - Providing lung tissue, blood samples and nasal secretions,
19814749
263-82-C-0037 - Providing lung tissue, blood samples and nasal secretions,
19814750
3A014501B71Q - Communicable diseases - immunology,
c.19664751
DA-49-007-MD-950 - Comparison of aqueous and adjuvant adenovirus vaccines,
19634752
DA-49-193-MD-2131 - Purification, characterization and synthesis of components of adenovirus,
19654753
DA-49-193-MD-2189 - Studies on the etiology and epidemiology of acute respiratory infections,
19654754
DA-49-193-MD-2495 - Genetic relationships among human and animal strains of influenza virus,
19674755
DA-49-193-MD-2795 - Recombination and transmission studies with influenza virus,
19714756
DADA-17-70-C-0121 - Purification, characterization, and synthesis of components of adenovirus,
19714757
M4305.01-1011 BFG6; M4305.01-1012 BFG6 - Epidemiology and prevention fo acute respiratory disease in navy recruits,
1972481
NIH-69-91 - Laboratory and antigenic studies of RSV; evaluation of respiratory syncytial, mimingococccal, and pneumococcal polysaccharide vaccines,
1970482
NIH-69-2072 - Research and development of adenovirus vaccines and parainfluenza virus vaccines,
1970483
NIH-69-2109 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness,
1969484
NIH-71-2091 - The assessment of antigenicity and effectiveness of respiratory disease vaccines,
1971485-6
NIH-71-2196 - Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children,
1971, 1973487
N01-AI-01528 - New viruses in relation to clinical diseases,
1968-1972488-9
N01-AI-02638 - Operation of a virus vaccine production laboratory,
1980-1981, 1983-19874810
N01-AI-02653 - Center for the clinical testing of bacterial vaccines, respiratory virus vaccines and antivirals,
19814811-13
N01-AI-05057 - University of Puerto Rico,
1991-19924814-15
N01-AI-05067 - Care and housing of AIDS research animals,
1990-19914816
N01-AI-17757 - Children's Hospital,
1980-19814817-19
N01-AI-22503 - Clinical evaluation of respiratory viral and bacterial vaccines in children and adults,
1972-19894820
N01-AI-22504 - Development of attenuated mutants of respiratory syncytial virus and parainfluenza viruses as potential vaccine strains,
19744821
N01-AI-22508 - Clinical evaluation of influenza virus vaccines,
19744822
N01-AI-35154 - Protocol relating to the passage, history, production, safety testing and characterization of an experimental live virus vaccine pool of influenza A/Beijing/352/89 (H3N2) . . .,
1993-1994491-2
N01-AI-32521 - Operation of a virus laboratory in support of LID,
1974-1990493-4
N01-AI-42510 - Preparation of isolated hemagglutinin, neuraminidase, matrix, and nucleoprotein subunits of influenza viruses and assay of their immunogenicity,
1978495
N01-AI-42528 - Influenza research center,
1979496
N01-AI-52565,
1985-1987497-8
N01-AI-72535 - Establishment of an infectious enteric disease study,
1978-1979499-10
N01-AI-82681 - Operation of an experimental virus vaccine production laboratory,
1988-19894911
N01-AO-52703 - Care and housing of AIDS research animals,
1997-19984912
N01-AO-52706 - Facility for non-human primates utilized in infectious disease research,
19984913
PH-40-30-64 - Development of a technique for virus and viral subunit isolation from large volumes of tissue culture,
19664914
PH-43-62-80 - Production of enterovirus antisera,
19654915
PH-43-62-127 - Preparation of immune serum to enteroviruses,
19654916
PH-43-62-129 - Standardization of picornavirus immune sera,
19654917-26
PH-43-62-473; PH-43-66-917 - Antigenicity and protection studies on inactivated 100X concentrated RSV vaccine and inactivated 100X concentrated parainfluenza 1 virus vaccine,
1962-19704927-29
PH-43-62-477 - Respiratory virus vaccine evaluation and surveillance,
1966-19684930-32
PH-43-62-487 - Research and development of rhinovirus, mycoplasma pneumoniae, and RS vaccines,
1966-19684933
PH-43-62-839 - Preparation of mycoplasma antigene and antisera,
19654934-35
PH-43-63-75 - Respiratory disease surveillance and vaccine studies in military dependent children,
1968, 19704936-38
PH-43-63-76 - Viral respiratory disease and immune response in the aged and in a pediatric population,
1966-1968501-4
PH-43-63-79 - Research and development of adenovirus vaccines and parainfluenza virus vaccines and adaptation of RSV to embryonated eggs of several avian species,
1964-1966505-6
PH-43-63-80 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illnesses,
1965, 1967507
PH-43-63-81 - Development, growth and characterization of virus induced tumor cells,
1967508
PH-43-63-90 - Upper respiratory virus,
1965509
PH-43-63-103 - Operation of a serology and tissue culture developmental laboratory,
19665010-11
PH-43-63-562 - Prevention of viral respiratory infections,
1964, 19685012
PH-43-63-563 - Vaccine studies in a children's center,
19685013
PH-43-63-564 - Research on attenuation of rhinoviruses and methods for measuring antibody response to rhinovirus infection,
19675014-16
PH-43-63-582 - Respiratory disease vaccine,
1962-19675017-18
PH-43-63-1128 - Surveillance of respiratory infections in an industrial population,
1966, 19685019-20
PH-43-63-1141 - Surveillance of viral respiratory diseases and vaccine evaluation in a pediatric population,
1967-19685021
PH-43-63-1163 - Studies on the response of primates to respiratory syncytial virus,
19645022
PH-43-63-1174 - World Health Organization Reference Centre for Enteroviruses,
19655023
PH-43-63-1177 - Reference seeds for echo and coxsackieviruses,
19655024
PH-43-64-529 - Preparation and development of viral reagents,
19655025-27
PH-43-64-928 - Molecular structure of oncogenic and non-oncogenic adenoviruses and the mechanism of viral carcinogenesis,
1966, 1968, 19725028-29
PH-43-64-943 - Developmental study relating to the preparation of a respiratory syncytial virus vaccine,
1966-19675030-32
PH-43-64-1169 - Oncogenicity testing of candidate viral respiratory vaccine strains and tumor reagent programs,
1965-19675033-34
PH-43-65-562 - Rhinovirus reference laboratory,
1966-19675035-36
PH-43-65-563 - Studies of RSV vaccines,
1966-19675037
PH-43-65-1004 - Characterization and propagation of live rubella vaccine candidate strains and production reagents,
19685038-40
PH-43-65-1031 - Study of vaccines for immunization against viral respiratory infections,
1966-19685041
PH-43-66-63 - The testing of experimental respiratory agents and vaccines in volunteers,
19665042-43
PH-43-66-93 - Rubella vaccine development,
1967-19685044
PH-43-66-99 - Research on the feasibility of preparing inactivated and/or attenuated rubella virus vaccines,
19675045
PH-43-66-459 - Research and development of attenuated and inactivated rubella vaccines,
19685046-47
PH-43-66-461 - Research and development of an inactivated rubella virus vaccine,
1967-19685048
PH-43-66-462 - Epidemiology of respiratory disease in total natural community and evaluation of immunizing agents,
19665049
PH-43-66-464 - Studies on the detection of rubella virus and its immunogenicity for animals and man,
1966-19685050
PH-43-66-565 - Development of a live vaccine for human influenza,
19665051-52
PH-43-66-917 - The role of infection in precipitating sudden deaths in infants,
19695053-54
PH-43-66-951 - Maintenance of a marmoset colony under strict isolation conditions,
1967-19685055
PH-43-66-970 - Operation of a tissue culture developmental laboratory,
19675056
PH-43-66-971 - Provide for the operation of a serology laboratory,
19675057-58
PH-43-67-48 - Longitudinal studies of acute respiratory diseases in children,
1968, 19705059-60
PH-43-67-75 - The testing of rubella virus vaccines in human volunteers,
1967-19685061
PH-43-67-76 - Identification, characterization, purification and concentration of the antigens of respiratory syncytial virus,
19685062
PH-43-67-77 - Biologic and antigenic studies with rubella virus,
19685063
PH-43-67-78 - The influence of cultural conditions and concentration procedures on the antigenicity of mycoplasma pneumoniae vaccines,
19685064-65
PH-43-67-79 - Study of the antigenicity and immunogenicity of mycoplasma pneumoniae vaccines,
19675066
PH-43-67-80 - Studies of rubella vaccine efficacy,
19675067
PH-43-67-91 - Research and development of respiratory disease vaccines,
1967-19685068
PH-43-67-681 - Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines,
19735069
PH-43-67-692 - Search for virus-specific genetic material in human cancers and studies on the mechanism of viral carcinogenesis,
19695070-71
PH-43-67-745 - Studies of local antibody in respiratory viral immunity,
1967, 19695072
PH-43-68-81 - Operation of a rubella virus service laboratory,
19685073
PH-43-68-83 - Primary immunization of infants with group A streptococcal M protein,
19685074
PH-43-68-692 - Research and development of rhinovirus and mycoplasma pneumoniae vaccines,
1968511-4
PH-43-68-1309 - Development of chemically induced conditional-lethal temperature-sensitive (ts) mutants of RS and parainfluenza viruses,
1968-1975515-6
PH-43-68-1316 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness,
1968-1969517
Z01-AI-00024 - Laboratory studies of myxoviruses, paramyxoviruses and respiratory syncytial virus,
1977518
Z01-AI-00175 - Laboratory studies of paramyxoviruses and respiratory snycytial virus,
1978-1981
Cooperative Research and Development Agreements (CRADA),
1972-2003519
License agreements,
1988-19965110-11
Chiron,
1988-20035112-15
Intracel,
1995-19975116-21
Lederle,
1992-2000521-10
Lederle (cont'd),
1992-20005211
MedImmune,
20025212
Praxis,
1987-19885213
Upjohn,
19885214-27
Wyeth,
1972-2001531-5
Wyeth (cont'd),
1972-2001
Series 4: Patents,
1966-2008536-7
Chanock's patents,
1967-2000538-10
Patent status reports,
2002-20085311
Confluent growth of mycoplasma - application,
1966-19675312-15
#3,317,393 - Immunization by selective infection of the intestinal tract with an encapsulated live virus,
1967-20055316-17
#3,992,522 - Temperature sensitive recombinant mutant viruses and a process for producing same,
1974-19765318
#4,552,757 - Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus,
1984-19885319-20
#4,571,385 - Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors,
1995-19995321-29
#4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth),
1998-2005541-4
#4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth) (cont'd),
1998-2005545
#4,751,080 - Vaccine against rotavirus diseases,
1988546-9
#4,800,078 - Immunotherapeutic method of treating respiratory disease by intranasal administration of IGB,
1966-19935410
#5,646,033 - African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines,
19975411-18
#5,762,905 - Human neutralizing monoclonal antibodies to respiratory syncytial virus,
1995-20045419
#5,882,651 - Attenuated respiratory syncytial virus vaccine compositions,
19935420
#5,911,998 - Method of producing a virus vaccine from an African green monkey kidney cell line,
19995421
#5,922,326 - Attenuated respiratory snycytial virus vaccine compositions,
19935422
#6,117,667 - Method for producing an adapted virus population from an African green monkey kidney cell line,
20005423-33
#6,184,024 - Chimeric and/or growth restricted flaviviruses,
1992-2007551-2
#6,184,024 - Chimeric and/or growth restricted flaviviruses (cont'd),
1992-2007553-9
#6,497,884 - Chimeric vaccine against tick-borne encephalitis virus,
2000-20075510
#6,660,273 - Chimeric vaccine against tick-borne encephalitis virus,
20035511-12
#6,676,936 - Chimeric and/or growth-restricted flaviviruses,
1998-19995513-19
#6,794,174 - Full-length infectious cDNA clones of tick-borne flavivirus,
2001-20085520
#7,150,984 - Attenuated human rotavirus vaccine,
20065521
#7,364,737 - Human neutralizing monoclonal antibodies to respiratory syncytial virus,
20085522-25
#7,932,074 - Multivalent human-bovine rotavirus vaccine,
1998-20065526-28
#8,778,671 - Construction of West Nile virus and dengue fever chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus,
2001-2004
Series 5: Writings/Reprints,
1953-20075529
Chanock numbered bibliography (1-653),
2003
Numbered Articles by Dr. Chanock,
1953-20035530-34
1-5,
1953-1954561-144
6-151 [incomplete],
1954-1967
[missing 127, 149]
571-148
152-323 [incomplete],
1967-1976
[missing 169, 194, 200, 203, 209, 219, 221, 230, 236, 247, 250, 252-253, 257, 259, 290, 291, 293-295, 301, 310, 315, 319]
581-194
325-568 [incomplete],
1976-1989
[missing 330, 340, 342, 348, 350, 364, 370, 384, 396, 411, 443-444, 449-450, 460, 464-465, 467, 470, 471, 474-477, 479, 481-482, 502-503, 505, 509, 524-525, 527, 532, 534, 537, 540-542, 546, 551-552, 557-558, 560, 563-566]
591-46
570-653 [incomplete],
1989-2003
[missing 574, 576, 579-581, 584, 586, 589-594, 597-600, 602, 605, 608, 611-612, 615, 618, 620-623, 625, 629-630, 641-644, 647-649]
Unnumbered Reprints by Dr. Chanock,
1954-20055947
Respiratory syncytial vaccine - with Murphy, Collins, and Olmsted,
undated5948
Recovery and characterization of hemagglutinins from two immunologically distinct types of dengue virus - with Sabin and Sweet,
c.19545949
III. Production of illness and clinical observations in adult volunteers,
19615950
Primary atypical pneumonia,
19665951
Genetic approaches to the prevention of influenza A virus infection - with Murphy,
19815952
Strain-specific serum antibody response in infants undergoing primary infection with respiratory syncytial virus - with Hendry, Burns, Walsh, Graham, Wright, Hemming, Rodriguez, Kim, Prince, McIntosh, and Murphy,
19885953
Antigenic analysis of the dengue virus envelope glycoprotein using synthetic peptides - with Markoff, Bray, Lai, Eckels, Summers, Gentry, Houghten, and Lerner,
19885954
Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev,
2005
Drafts by Dr. Chanock,
c.1960s-c.20075955
Untitled fragments,
undated5956
Acute respiratory disease of infancy and childhood - present understanding and prospects for prevention,
undated5957
Blueprint for use of live virus vaccine to prevent a pandemic of influenza A virus - with Murphy and Spring,
undated5958
Decreased virulence and protective effect of a genetically stable temperature-sensitive mutant of m. pneumoniae in human volunteers,
undated5959
Infection of immature white mice by the addition of western equine encephalitis virus to the feed,
undated5960
Parainfluenza, respiratory syncytial, and New Castle disease viruses - with Parrott (title page only),
undated5961
Development of immunity - outline,
c.1960s5962
Prospects for control of auto viral mycoplasmal respiratory tract disease by vaccination,
c.1960s5963
Untitled draft re pediatric respiratory illnesses at Camp Lejeune 1959-1963,
c.19645964
The contribution of adenoviruses to respiratory tract illness among children,
c.19655965
The relationship of mycoplasma pneumoniae to pediatric respiratory tract disease - with Canchola, Brandt, Kim, and Parrott,
19705966
Guide for the collection and transport of virological specimens,
19755967
Virus and mycoplasma pneumoniae in respiratory disease patients, January 1975-June 1976 - with Brandt, Kim, Arrobio, and Parrott,
c.19775968
Isolation and characterization of temperature-sensitive mutants of influenza A virus,
19775969
Bovine respiratory syncytial virus: studies in experimental animals - with Prince, Suffin, Horswood, Camargo, Prevar, and Sly,
19805970
Respiratory syncytial virus in cotton rats: growth, antigenicity and protective efficacy of two temperature-sensitive, live virus vaccine candidates, ts-1-NG-1 and ts-1-NG-16 - with Prince, Horswood, Prevar, Camargo, Suffin, and Spring,
19805971
HLA antigens in severe respiratory syncytial virus disease in infants and early childhood - with Johnson, Kiim, Hartzman, Parrott, Woody, and Sell,
19815972
Studies of avian-human reassortant influenza A viruses in seronegative (HAE<1:8) adult volunteers, 1984-86 - with Clements, Murphy, Snyder, Buckler-White, Tierney, Betts, Dolin, Black, and Sears,
19865973
Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations,
19915974
A live cold-passaged temperature-sensitive mutant of human respiratory syncytial virus is highly attenuated, genetically stable, immunogenic, and efficacious against wild type challenge in seronegative chimpanzees,
19935975
"Cold-passaged and temperature sensitive (ts) derivatives of the partially attenuated respiratory syncytial virus ts-4 mutant are more restricted in replication in mice - with Crowe, Jr., Hsu, Lubeck, and Murphy,
c.19945976
Short summary of studies of chimeric viruses as candidates for live attenuated vaccine against tick-borne encephalitis,
2000-20055977
Comparison of live and inactivated tick-borne encephalitis virus vaccines for immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev,
20055978
Early experiences with influenza adjuvated vaccines,
c.2007
Untitled Drafts by Dr. Chanock,
c.1955-c.20075979
Miscellaneous individual pages,
undated5980
The interplay of immunologic factors in acute viral respiratory tract disease,
undated5981
pages 16-22 re ts mutants,
undated5982
There is compelling evidence that local immunity plays a major role in resistance to most respiratory viral pathogens,
undated5983
re temperature-sensitive mutants,
undated5984
re vaccines against RSV,
undated5985
re arthropod-borne encephalitis viruses,
c.19555986
pages 3-15 re RS virus,
c.19625987
report on tests of inactivated respiratory virus vaccines,
c.1967-19685988
mycoplasma pneumoniae,
19735989
RS virus (RSV) is the major viral pathogen of the respiratory tract,
19755990
Respiratory syncytial (RS) virus is the major etiologic agent of bronchiolitis,
19765991
pages 25-90 of "f-rot.doc",
19895992
Evaluation of antibody response to RSV,
19905993
pages 9-29 re serum RSV antibodies,
c.19945994
re vaccine against TBEV,
c.20025995
re Langat virus (LGT) - with Kyle,
20025996
re flaviviridae tick-borne encephalitis viruses (TBEV),
20045997
re protective immune response against 1918 influenza virus,
c.2007
Books Inscribed to Dr. Chanock,
1998-2004601
Textbook of Military Medicine - Part I Warfare, Weaponry and the Casualty,
1998602
Hantavirus hunting - by Ho-Wang Lee,
2004
Series 6: Meetings,
1954-2005603
Proceedings of the Conference on Complement Fixation,
5 August 1954604-5
Proceedings of the Conference on Neutralization,
18-20 May 1955606
Proceedings of the Round Table Conference on Genetic Aspects of Virus-Host Cell Relationships with Particular Reference to Polioviruses,
23-24 February 1956607
Society for Pediatric Research annual meeting,
8-9 May 1959608
Meetings - general,
1960609
Meetings - general,
19616010-11
Russian trip,
May 19616012
Meeting in Prague, Czechoslovakia,
23-27 May 19616013
World Health Organization, Geneva,
15-21 August 19616014
Meetings - general,
19626015
International Postgraduate Course Respiratory Virus Diseases,
11-14 April 19626016
Newer Respiratory Disease Viruses,
3 October 19626017
Meetings - general,
19636018
World Health Organization Respiratory Virus meeting,
1-6 July 19636019
University of Wisconsin Symposium on New Castle Disease,
15 July 19636020
7th International Congress on Tropical Medicine,
1-11 September 19636021
Seminar on Respiratory Disease,
9 October 19636022
Meetings - general,
19646023
American College of Physicians,
6-10 April 19646024
World Health Organization directors,
20-27 July 19646025
Meetings - general,
19656026
Rhinovirus workshop,
25 January 19656027
American Society of Clinical Investigation,
3 May 19656028
World Health Organization,
27 September 19656029
Armed Forces Epidemiological Board Commission on Viral Infections,
14-15 October 19656030
International Congress of Pediatrics,
7 November 19656031
Conference on Acute Infectioius Respiratory Diseases,
14-15 December 19656032
Meetings - general,
19666033
Mycoplasma conference,
9-11 February 19666034
American Society for Clinical Investigation,
1 May 19666035
New York Academy of Science,
11 May 19666036
Conference on Live Oral Adenovirus Vaccine in Marine and Navy Recruits,
10-11 June 1966611
Pan American Health Organization,
7 November 1966612
Meetings - general,
1967613-4
Human Vaccines - Possible Oncogenic Implications,
9 January 1967615
Laboratory Methods in the Isolation and Identification of Respiroviruses and Enteroviruses,
3-4 July 1967616
Respiratory Syncytial Virus Workshop,
10 July 1967617
Conference on Measles Virus, etc.,
13 September 1967618
Scientific Group on Respiratory Viruses,
9-14 October 1967619
American Academy of Pediatrics,
25 October 19676110
Symposium honoring Dr. M. D. Eaton,
1 December 19666111
Meetings - general,
19686112
Clinical at the College of Physicians and Surgeons, Columbia, University,
27 January 19686113-14
Gustav Stern Symposium on Perspectives in Virology,
29 January 19686115
American Academy of Allergy,
5-7 February 19686116
American Epidemiological Society,
29-30 March 19686117
American Medical Association,
23-24 April 19686118
American Society for Clinical Investigation,
5 May 19686119
Society for Epidemiological Research,
10-11 May 19686120
Postgraduate Workshop, University of Maryland,
2 June 19686121
Third International Symposium on Aerobiology,
15-19 September 19686122
Influenza Genetics,
11-12 November 19686123
Armed Forces Epidemiological Board Committee on Influenza,
18-20 November 19686124
Twelfth International Congress of Pediatrics,
1-7 December 19686125
Meetings - general,
19696126
Vaccine Development Committee meeting,
27-28 January 19696127
International Conference on Rubella Immunizations,
18-20 February 19696128
Conference on Immunology,
2 April 19696129-30
World Health Organization Virus Reference Centres meeting,
22-25 April 19696131
American Society for Microbiology,
4-9 May 19696132
American Society for Clinical Investigation,
5 May 19696133
American Thoracic Society,
24-26 May 19696134
Gustav Stern meeting,
25-26 May 19696135
Ad hoc Conference on Australia Antigen and Hepatitis,
23-24 June 19696136
Vaccine Development Workshop on Vaccine Testings,
27 June 19696137
Virus Diseases of the Respiratory Tract,
23 September 19696138
International Working Conference on Influenza,
14-16 October 19696139
Infectious Disease Society of America,
25-26 October 19696140
International Conference on Vaccines against Viral and Rickettsial Diseases of Man,
7-11 November 19696141
Committee on Influenza,
17-19 November 19696142
NICHD Immunology Workshop,
11-13 December 19696143
Secretory Antibody,
10-13 December 19696144
Human Responses to Viral Antigens,
3 August 19716145
Mycoplasma and Mycoplasma-like Agents of Animal and Plant Diseases,
8-10 January 19736146
Influenza Workshop IV,
24 January 19736147
Acute Respiratory Diseases,
8-9 March 19736148
Influenza Vaccines, University of Maryland,
13 March 19736149
Fogarty Center Conferences on Preventive Medicine,
15-16 March 19736150
ICN/UCLA Symposium on Molecular Biology-Virus Research,
18-23 March 19736151
New Approaches for Inducing Natural Immunity to Pyogenic Organisms,
20-23 March 19736152
Influenza Workshop V on Influenza Vaccines,
3-4, 14 April 1973621
Influenza Workshop V on Influenza Vaccines (cont'd),
3-4, 14 April 1973622
American Epidemiological Society,
6-7 April 1973623
Epidemic Intelligence Service Conference,
9-13 April 1973624-5
Directors of World Health Organization Reference Centers,
16-19 April 1973626
U.S.-Japan Program,
23-27 July 1973627-8
Problems of Bacteriophage Contamination,
1 August 1973629
FIC Subcommittee on Infectious Diseases,
14-16 September 19736210
Infectious Diseases Society of America,
17-18 September 19736211
Parainfluenza and RS Candidate Vaccines,
5 October 19736212
Animal Influenza and its Significance for Human Infections,
11-12 October 19736213
University of Chicago Alumni Banquet,
23 October 19736214
National Academy of Sciences,
23 October 19736215
Interagency Meeting on Influenza,
19 November 19736216-17
World Health Organization,
1-5 September 19756218
Joint Working Conference of the Virus Cancer Program,
3-5 November 19756219
Influenza meeting, NIH,
12 January 19766220
Influenza Program Review meeting, NIH,
15-16 January 19766221
Working Group on Pandemic Influenza,
26-28 January 19766222
Bacterial and Viral Gastroenteritis,
5-6 February 19766223
Bureau of Biologics,
20 February 19766224
Walter Reed Ad Hoc meeting,
8 March 19766225
Armed Forces Epidemiological Board,
12 March 19766226
Bureau of Biologics,
25 March 19766227
Current Status and Prospect for Improved and New Bacterial Vaccines,
29 March-1 April 19766228
Influenza meeting, NIH,
15 April 19766229
National Academy of Sciences,
26-28 April 19766230
American Epidemiological Society,
29 April-1 May 19766231
Association of American Physicians,
30 April-2 May 19766232
American Society for Microbiology,
2-7 May 19766233
Association of American Physicians,
4 May 19766234
Conference on Persistent Viral Infections,
13-16 June 19766235
Bureau of Biologics,
21-22 June 19766236
Bronchiolitis workshop,
28-29 June 19766237
Festschrift for Albert Sabin,
26 August 19766238
Consensus Development on Use of Amantadine,
15-16 October 19766239
Infectious Disease Society of America,
25-26 October 19766240
Ad Hoc Viral and Rickettsial Disease Study Group,
8 November 19766241
Viral and Bacterial Vaccines, Present Knowledge and Future Development International Symposium,
7-8 September 19776242
Chinese delegation,
19796243
Experimental Herpesvirus Vaccine workshop,
7-9 February 19796244
Surgeon General's Meeting on Influenza,
12 February 19796245
Medical Research Council,
20 February 19796246
Symposium on Potentiation of Immune Response to Vaccines,
20-21 February 19796247
The Royal Society Meeting on Influenza,
21-22 February 1979631
Secretary's Conference on Influenza,
6 March 1979632
Attenuated Influenza Vaccine workshop, NIH,
9 March 1979633
American Physicians Fellowship Program, NIH,
29-30 March 1979634
American Epidemiological Society,
30-31 March 1979635
Vaccine Studies in the Elderly,
30 April 1979636
American Society for Microbiology,
4-11 May 1979637
Influenza B Viruses workshop,
30-31, 1979638
Prevention of Major Infectious Diseases: Current Concerns and Future Promise,
20-21 September 1979639
Medical Society of the District of Columbia,
27-28 September 19796310
Infectious Diseases Society of America,
5-6 October 19796311
Molecular Approaches to Vaccine Development,
10 October 19796312
U.S.-U.S.S.R. Influenza meeting,
16-18 October 19796313
Genetic Variation of Viruses,
28-30 November 19796314
Australian Commonwealth Scientific and Industrial Research Organization,
10-12 December 19796315
Perspectives in Virology,
4-5 February 19806316
Australian Academy of Science,
8-12 February 19826317
Duke University seminar,
4 February 19806318
Attenuated Vaccines,
10 March 19806319
Pritzker School of Medicine Council meeting,
2 May 19806320
American Society for Microbiology,
11-16 May 19806321
Eradication of Infectious Diseases,
27-28 May 19806322
Infectious Disease Society of America,
25-26 September 19806323
Negative Strand Viruses,
27 October-1 November 19806324
World Health Organization Consultation on Influenza,
5-6 November 19806325
Department of Microbiology and Molecular Genetics seminar,
2 December 19806326
ICN/UCLA Symposium on Genetic Variation of Influenza Viruses,
8-13 March 19816327
International Symposium on Viral Hepatitis,
30 March-2 April 19816328
Department of Microbiology and Immunology seminar, Duke University,
16 April 19816329
Mt. Sinai Symposium on Infections Caused by Enteric Viruses,
4 June 19816330
International Congress of Virology,
2-7 August 19816331
Respiratory Diseases meeting,
16 October 19816332
Workshop on Respiratory Diseases,
21-22 June 19826333
International Symposium on Polilomyelitis Control,
14-17 March 19836334
NIAID Workshop on AIDS,
5-6 April 19836335
Towards New Vaccines Against Virus Infections,
21-23 June 19836336
London Conference on Influenza,
21-23 September 19836337
Association of American Physicians,
29 April-2 May 19836338-47
Modern Approaches to Vaccine,
31 August-4 September 19836348
Negative Strand Virus meeting,
11-17 September 19836349
International Conference on Immunobiology and Prophylaxis of Human Herpesvirus Infections,
9-12 October 19836350
19th Immunization Conference - proceedings,
21-24 May 19846351
International Congress of Virology,
1-7 September 19846352
International Workshop on the Molecular Biology of Flaviviruses,
29 November-1 December 19846353
Status of Attenuated Influenza Vaccines,
10-11 December 19846354
Rowe Symposium,
11-12 February 19856355
Rotavirus Vaccine Work Group,
13 March 19856356
Genetically Altered Viruses,
28 April-1 May 1985641
American Society for Virology,
21-25 July 1985642
World Health Organization Steering Committee on Acute Respiratory Viruses,
29-30 July 1985643-5
Modern Approaches to Vaccines,
11-15 September 1985646
The Biology of Negative Strand Viruses,
15-20 September 1985647
Expression of Foreign Genes,
4-7 October 1985648
RSV Symposium,
16 October 1985649
Duke University Academic Visiting Professor,
16-18 December 19856410
Scripps Scientific Review Committee,
13-15 January 19866411
Rowe Symposium,
3-4 February 19866412
Vaccinia-Vectoring,
31 March 19866413
Cosmos Club award, Albert Sabin,
15 April 19866414
Vaccine Supply and Innovation workshop,
24-25 April 19866415
Association of American Physicians,
2-4 Mary 19866416
Influenza Viruses,
20 May 19866417
World Health Organization Acute Respiratory Viruses meeting,
27-28 June 19866418
FEBS meeting,
24-29 August 19866419
Infectious Diseases Society of America,
2-3 October 19866420
Scripps Scientific Review Committee,
10 January 19876421
Rowe Symposium,
2-3 February 19876422
AIDS Vaccines workshop,
25-27 March 19876423
Workshop on Respiratory Syncytial and Parainfluenza Viruses,
4-5 May 19876424
Scholars-in-Residence symposium,
11-14 May 19876425
Pasteur Centenary Symposium,
26-28 May 19876426
American Society for Virology,
31 May-4 June 19876427
International Conference on AIDS,
1-5 June 19876428-29
Nobel Symposium on the Vaccines of the Future,
23-26 August 19876430
International Symposium on Infectious Diseases,
11-12 November 19876431
Live Viral Vaccines for Respiratory and Enteric Tract Diseases,
24 November 19876432
Conference on the Development of Vaccines Against HIV and AIDS,
14-15 December 19876433
Scripps Scientific Review Committee,
14 January 19886434
Conference on Poliomyelitis Vaccines: Re-evaluating Policy Options,
21-22 January 19886435
Rowe Symposium,
1-2 February 19886436
National Academy of Sciences Committee on International Security and Arms Control,
16 March 19886437
Oral Immunization symposium,
21-22 March 19886438
NIH Seminar,
6 April 19886439
American Pediatric Society Centennial Celebration,
3 May 19886440
National Academy of Sciences and Academy of Sciences of the USSR on Biological Weapons,
9-11 May 19886441
Wagner Symposium,
15-16 May 19886442
Live Attenuated Influenza Virus Vaccine,
26 May 19886443
American Society for Virology,
12-16 June 19886444
NIH Rotavirus Vaccine workshop,
8-9 September 19886445
Modern Approaches to New Vaccines Including Prevention of AIDS,
14-18 September 19886446
Immunology of Virus Diseases,
26-28 October 19886447
Genetic Basis of Human Disease,
30 November-1 December 19886448
Institute of Medicine Research Briefing Panel,
27-28 April 19896449
Symposium on Respiratory Virus Vaccine Development,
1 May 19896450
American Society for Virology,
9-13 July 19896451-52
Modern Approaches to New Vaccines Including Prevention of AIDS,
20-24 September 19896453
International Conference on Comparative and Applied Virology,
15-21 October 19896454
Rowe Symposium,
5-6 February 19896455-56
American Thoracic Society,
23 May 1990651
American Thoracic Society (cont'd),
23 May 1990652
International Congress of Virology,
26-31 August 1990653
Children's Vaccine Initiative,
6 August 1990654
Colloquium on Human Diseases - Molecular Mechanisms of Viral Pathogenesis,
19-20 October 1990655
Animal Models of Respiratory Syncytial Virus Infections,
24-25 October 1990656
NIH Rotavirus Vaccine Workshop,
5-6 November 1990657
Rowe Symposium,
4-5 February 1991658
Saul Krugman Festschrift,
12 April 1991659
Inauguration of Richard M. Haidack Distinguished Professorship in Medicine,
29 May 19916510
Pathogenesis Symposium,
5 December 19916511
Rowe Symposium,
3-4 February 19926512
NIAID Interdivisional AIDS Working Group,
24 April 19926513
Measles workshop,
14-15 September 19926514
Lounsbury Award Jury Dinner,
5 November 19926515
Innovations in Therapy of Human Viral Diseases,
6-7 December 19926516
Molecular Pathogenesis of Infections and Tumors,
5-6 May 19946517
Scientific Symposium to Honor the Work of Janet W. Hartley,
13 September 19946518
Scientific Meeting of the Australian Society for Microbiology,
26-30 September 19946519
Molecular Approaches to the Control of Infectious Diseases,
5-9 October 19946520-21
Frank and Bobbie Fenner Conference in Medical Research,
28-30 November 19946522
Office of Science and Technology Policy meeting,
29 March 19956523
Fogarty Advisory Board,
23 May 19956524
Igor Tamm Memorial Symposium,
30 November 19956525
Thomas Merigan Lecture,
23-29 May 19966526
Conference on Immunoglobulins,
2-4 June 19966527
Antibody workshop,
2-4 June 19966528
Simian Virus 40 workshop,
27-28 January 19976529-30
NIAID Principal Investigators' retreat,
20-21 November 19976531
Center for Biologics Evaluation and Research, Vaccines and Related Biological Products Advisory Committee,
19-20 Novebmer 19986532
American Epidemiological Society,
18-19 March 19996533
Memorial Symposium for Robert Huebner,
11 November 19996534
Conference on Vaccine Research,
1-2 May 20006535
NIAID Principal Investigators' workshop,
6-7 November 20006536
NIAID Principal Investigators' workshop,
14-15 November 20026537
RSV 2003 Symposium,
8-11 November 20036538
Trans-NIH/FDA Intramural Biodefense Symposium,
7-8 April 20046539
Rotavirus Symposium,
7-9 July 20056540
RSV Symposium,
15-18 September 2005
Series 7: Lectures and Speeches,
1951-20056541
Control of pediatric viral diseases: past successes and future prospects,
undated6542
Untitled ["There seems little reason to doubt that antibody in serum is an important mediator"],
c.1950s6543
Hemagluttination with the virus of western equine encephalitis - with Sabin,
30 November 19516544
Hemagglutinins of St. Louis and western equine viruses - isolation, properties, and use for diagnosis and epidemiologic survey,
5 May 19526545
The Hemagglutination test for Japanese encephalitis, a diagnosis and survey tool,
19556546
Untitled ["I'd like to start off by describing in some detail, of course I'll probably be offending some, viruses and some of the tests we use in"],
25 November 19586547
Mycoplasma pneumoniae infections - prospects for live and inactivated vaccines,
c.19636548
Infections caused by mycoplasmas,
4 November 19656549
Australia antigen and serum hepatitis,
19706550
Untitled [at International Congress of Microbiology],
August 19706551
Parainfluenza virus epidemiology,
3 May 19746552
Untitled ["For approximately the past five years the Laboratory of Infectious Diseases at the NIH in Bethesda has been involved in the study of acute infectious nonbacterial gastroenteritis."],
September 19756553
Untitled ["This morning I would like to discuss two areas of study in which we have been involved concerning human reovirus-like agent of infantile gastroenteritis.",
19766554
Chicago talk,
19776555
R. E. Dyer lecture,
30 May 19786556
Medicine for Laymen series lecture,
4 December 19796557
Smadel lecture at Infectious Diseases Society meeting,
26 September 19806558
Saz Immunology Lecture,
9 October 19856559
Successful strategy for selection and characterization of live poliomyelitis virus vaccine strains,
27 October 1986661
Feldman Memorial Lecture,
17-18 March 1987662
FAES lecture,
7 December 1988663-4
Talamo lecture,
4 April 1990665
Children's Hospital National Medical Center,
22 October 1990666
Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations,
7 February 1991667
Careers in virology: a good beginning is usually required for a good ending,
7 or 12 February 1991668
Albert Sabin eulogy,
1993669
Natural history of RSV,
19946610-11
Sabin Lecture, Cold Spring Harbor,
September 19956612
Untitled ["sabin.doc"],
19976613
Huebner Symposium lecture,
10 November 19996614
Speech in honor of Brian Murphy,
20036615
R. Walter Schlesinger, M.D. (1913-2003),
5 November 20036616
Tribute to Albertk Kapikian, honored with Albert Sabin Foundation Gold Medal,
16 May 2005
Series 8: Videocassettes,
1985-198767
Wallace P. Rowe Symposium [11 Umatic videocassettes],
12 February 198568
A Scientific Symposium in Honor of Albert B. Sabin's 80th Birthday [9 Umatic, 5 vhs videocassettes],
26 August 198668
Bldg10/ACRF [1 Umatic videocassette],
11 May 1987
Collection Scope and Content Note
Correspondence, lab notebooks, research reports and data, reprints, lectures, and conference notes document Dr. Robert M. Chanock's professional research career at NIAID's Laboratory of Infectious Disease studying and developing therapies for respiratory viruses that are particularly common in children, notably human respiratory syncytial virus (RSV) and the para-influenza viruses. Research strengths include a nearly comphrehnsive set of lab notebooks documenting the lab's work on Respiratory Syncytial Virus (RSV) and Paramyxoviridae infections and the business of collaborating with various pharmaceutical companies to produce vaccines.
Series 1, Personal and Biographical (1933-2008), includes correspondence (1950-1957) from research positions Dr. Chanock held before joining NIAID, at the University of Cincinnati and Johns Hopkins, and in the Army in Korea. Dr. Chanock's personal and family life are reflected in correspondence and congratulatory exchanges from colleagues (1933-2008) along with photographs (c.1950s-2005), oral history transcripts (2001-2003), and certificates and awards (1964-2008).
Series 2: NIH-NIAID-Laboratory of Infectious Diseases (LID) (1955-2008) contains incomplete sets of NIAID annual reports (1967-1983), LID annual reports (1966-1997), and LID Board of Scientific Counselor's Reviews (1978-2004). Correspondence (1955-2008) exists in varied orientations: a group arranged alphabetically by correspondent surname spans 1957 to 1979; chronological files are incomplete from 1968 to 1995 and are augmented by informally collected "chronological" files dated 1957-2008; there are also files, arranged alphabetically, by subject (1955-2007). Completing the series is a group of 35mm slide presentations (1961-2005), arranged chronologically, on LID research topics such as mycoplasma and respiratory syncytial virus.
Series 3, Research (1951-2008) is the largest portion of the collection and has many sections. Lab notebooks (1958-2000) are probably the most comprehensive and valuable part of this series. Arranged by surname of the LID researcher, they provide a day to day picture of research being conducted in the lab. The work of Dr. Chanock, Albert Kapikian, and Wallace P. Rowe are documented here, along with nine other researchers. A smaller set of lab notebooks designated by subject title, such as neuroaminidase, is arranged alphabetically. Research data, (1950-2008), is the least well described part of this series. Often these chronologically arranged folders bear brief titles, leaving only the material's date and context to aid in determining more specifically what studies they may pertain to. Cooperative Research and Development Agreements (CRADA) (1972-2003) with several pharmaceutical companies, notably Lederle and Wyeth, are arranged alphabetically by company name. Research contract reports range in date from 1952 to 1998. All of them after 1957 are contracts with NIAID. Most are arranged by contract number, the bulk of whose numbers are prefaced by "N01" or "PH". Proposals for research contracts which don't correspond to known contracts (1955-2001) are arranged chronologically. Investigational New Drugs (IND) reports (1963-2001) record results, in the form of supplements, of experimental drug testing by NIAID in collaboration with pharmaceutical companies. These are arranged by the Food and Drug Administration's assigned IND number. LID lab research reports (1960-2004) concern only documentation of studies undertaken in the NIAID lab without collaborators. These are arranged chronologically except in the few exceptions when contract numbers are evident.
Series 4, Patents (1966-2008) which Dr. Chanock co-invented, is arranged numerically by patent number. Related to each is material often in several folders documenting the patent submission and approval process, licensing to pharmaceutical companies, and applications for corresponding foreign patents.
Series 5, Writings/Reprints (1953-2007) contains an incomplete set of Dr. Chanock's scientific articles, which in their entirety total 653 (1953-2003). Smaller subsections of this series hold eight articles by Dr. Chanock which are not represented on his bibliography (1954-2007); drafts of articles not corresponding with his published work (c.1960s-c.2007); and untitled drafts and writing fragments (c.1955-c.2007). Reprints are arranged by number assigned in Dr. Chanock's bibliography. The other sections are chronological.
Series 6, Meetings (1954-2005) contains programs, proceedings, notes, and other related information collected by Dr. Chanock when he attended national and international health conferences focusing on virology. He regularly attended meetings held by the American Society for Clinical Investigation, World Health Organization, American Epidemiological Society, and American Society for Microbiology. The series is arranged chronologically.
Series 7, Lectures and Speeches (1951-2005) are arranged chronologically. While a number of the earlier speeches lack identification as to where or when they were delivered, most after 1970 were lectures given at conferences or on honorary occasions.
Series 8, Videocassettes (1985-1987) mostly cover two subjects: the February 12, 1985 Wallace P. Rowe Symposium, and the August 26, 1986 Scientific Symposium in Honor of Albert B. Sabin's 80th Birthday.
Contents List
|
Box | Folder
|
Title
|
| |
Series 1: Personal and Biographical,
1933-2008 [series]:
|
| 1 |
1 |
Biographical sketches,
1993-1998
|
| 1 |
2 |
Scrapbook,
1950-1973
|
| 1 |
3-6 |
CVs and bibliography,
1987-2004
|
| 1 |
7 |
High school essays,
1940-1941
|
| 1 |
8 |
University of Chicago - correspondence,
1942-1949
|
| 1 |
9 |
University of Chicago Medical and Biological Sciences Alumni Association - reunion class of 1947 - dinner menu and yearbook,
1997
|
| 1 |
10-12 |
University of Chicago - course notes, lab procedures, dietary formulations,
1948-1950
|
| 69 |
1 |
Sydenham Hospital patient records,
1948 [RESTRICTED PHI POLICY]
|
| 1 |
13 |
Medical license,
1976-1994
|
| 1 |
14 |
Army discharge,
1946
|
| 1 |
15-22 |
U.S. Army service in Korea - correspondence, orders, data,
1949-1955
|
| 69 |
3 |
U.S. Army - Korea - Q fever and scrub typhus,
1953 [RESTRICTED PHI POLICY]
|
| 1 |
23-26 |
University of Cincinnati College of Medicine fellow - correspondence, reports,
1950-1952
|
| 1 |
27 |
Children's Hospital Research Foundation - correspondence,
1955-1956
|
| 69 |
4 |
University of Cincinnati College of Medicine,
1955 [RESTRICTED PHI POLICY]
|
| 1 |
28-30 |
Johns Hopkins - correspondence, laboratory manual, notes,
1956-1957
|
| 1 |
31-34 |
PHS Commissioned Officer - orders, correspondence, identification, retirement,
1957-1988
|
| 1 |
35-37 |
National Institute of Allergies and Infectious Diseases Oral History Interview - conducted by Peggy Dillon,
2001-2003
|
| 1 |
38 |
Retirement guestbook,
c.2008
|
| |
Family Correspondence,
1933-1995 [subseries]:
|
| 1 |
39 |
From Robert to his family,
1933
|
| 1 |
40 |
From Robert to Beth Chanock,
1948-1955
|
| 1 |
41 |
Notes,
c.1950s
|
| 1 |
42 |
Well wishes on pericarditis,
1967
|
| 2 |
1 |
Family and friends,
1968-1995
|
| 2 |
2 |
Congratulations on birth of grandson,
1983
|
| 2 |
3 |
Chanock, Foster Osgood,
1975-1980
|
| 2 |
4 |
Chanock, Frances E.,
1995
|
| 2 |
5 |
Chanock, Stephen J.,
1971-1989
|
| |
Awards and Honors,
1945-2008 [subseries]:
|
| 2 |
6 |
Various certificates,
1945-2008
|
| 2 |
7 |
E. Mead Johnson Award for Research in Pediatrics - congratulations and correspondence,
27 October 1964
|
| 2 |
8 |
Kimble Methodology Award - letters of congratulations and correspondence,
31 October 1966
|
| 2 |
9 |
Infectious Diseases Society of America Squibb Award - congratulations, correspondence, and acceptance speech,
25 October 1969
|
| 2 |
10 |
DHEW Distinguished Service Medal - correspondence, photographs, and ceremony program,
15 April 1971
|
| 2 |
11 |
Gorgas Medal - announcement and clipping,
11 December 1972
|
| 2 |
12 |
Election to National Academy of Sciences - letters of congratulations,
1973
|
| 2 |
13 |
Howard Taylor Ricketts Award - announcement, congratulations, event program, lecture transcript,
14 May 1973
|
| 2 |
14 |
Award for Distinguished Achievement - announcement,
1976
|
| 2 |
15 |
University of Chicago - honorary doctorate - announcement, photographs, and convocation program,
14 November 1977
|
| 2 |
16-17 |
Robert Koch Stiftung Award - correspondence, letters of congratulations, ceremony program, photographs, lecture transcript,
7 December 1981
|
| 2 |
18-23 |
ICN International Prize in Virology - announcement, correspondence, letters of congratulations, ceremony program, photographs,
7 February 1991
|
| 2 |
24 |
Presidential Meritorious Executive Rank Award,
1993
|
| 2 |
25-26 |
Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Disease Research - announcement, letters of congratulations, ceremony program, and clippings,
7 December 1993
|
| 2 |
27 |
Albert B. Sabin Gold Medal Award - letters of congratulations, ceremony program, lecture transcript, and clippings,
14 September 1995
|
| 2 |
28 |
American College of Physicians Award for Outstanding Work in Science as Related to Medicine - correspondence,
May 2008
|
| |
Photographs,
c.1950s-2005 [subseries]:
|
| 2 |
29 |
Aboard the 'Independence',
c.1950s
|
| 2 |
30 |
Dr. Chanock's friends and colleagues,
c.1960s-2000s
|
| 2 |
31-33 |
Dr. Chanock - with family, in groups, in PHS uniform, at conferences, in laboratory,
1988-1998, undated
|
| 2 |
34 |
A celebration of the career of Dr. Robert M. Chanock, Laboratory of Infectious Diseases, NIAID, NIH,
21 October 2005
|
| |
Clippings,
1954-2008 [subseries]:
|
| 2 |
35-37 |
General,
1958-2008
|
| 3 |
1 |
Obituaries of colleagues,
1995-1998
|
| 3 |
2 |
re Influenza,
1947-1998
|
| 3 |
3 |
Virus discoveries,
1954-1980
|
| Born Digital |
|
Archive-It web archive, top results for "Robert Chanock" Google search conducted by HMD staff, 2018
[view online]
|
| |
Series 2: NIH-NIAID-Laboratory of Infectious Diseases (LID),
1955-2008 [series]:
|
| 3 |
4-14 |
NIAID Annual Reports,
1967-1972
|
| 4 |
1-14 |
NIAID Annual Reports (cont'd),
1973-1980
|
| 5 |
1-5 |
NIAID Annual Reports (cont'd),
1980-1983
|
| 5 |
6-13 |
LID Board of Scientific Counselors Review,
1978, 1981, 1984, 1987, 1992, 1996
|
| 6 |
1-11 |
LID Board of Scientific Counselors Review (cont'd),
1996, 2000, 2003, 2004
|
| 6 |
12-23 |
LID Annual Reports [3.5 computer disks],
1966-1970; 1972-1973, 1976, 1982, 1984, 1985, 1987
|
| 7 |
1-14 |
LID Annual Reports (cont'd),
1987-1996
|
| 8 |
1-2 |
LID Annual Reports (cont'd),
1996-1997
|
| 8 |
3-35 |
Calendar - Dr. Chanock's,
1971-2006
|
| |
Correspondence,
1955-2008 [subseries]:
|
| 8 |
36-50 |
Alphabetical by correspondent - A-H,
1957-1968
|
| 9 |
1-19 |
Alphabetical by correspondent - H-W,
1957-1968
|
| 9 |
20-25 |
Alphabetical by correspondent - A-L,
1969-1975
|
| 10 |
1-6 |
Alphabetical by correspondent - M-Z,
1969-1975
|
| 10 |
7-24 |
Alphabetical by correspondent - A-T,
1975-1996
|
| 10 |
25-27 |
Alphabetical by correspondent - A-Z,
1978-1979
|
| 10 |
28 |
Becker, Walter B.,
1963-1971
|
| 10 |
29 |
Brown, Fred,
1989-1992
|
| 10 |
30 |
Children's Hospital, Philadelphia - Dr. Lief,
1964-1966
|
| 10 |
31 |
Croup agent,
1955-1958
|
| 10 |
32 |
Fenner, Frank,
1978-1997
|
| 10 |
33 |
Roizman, Bernard,
1974-1988
|
| 10 |
34 |
Siim, J. Christian,
1979-1991
|
| 10 |
35 |
Stuart-Harris, Charles,
1977-1983
|
| 10 |
36 |
Syrucek, Lubomir,
1965-1972
|
| 10 |
37 |
Walter Reed Army Medical Center,
1962-1969
|
| 10 |
38 |
Wyeth Laboratories,
1964-1969
|
| 10 |
39-41 |
Chronological Files,
1968, 1971-1972
|
| 11 |
1-21 |
Chronological Files,
1973-1981, 1984-1986, 1989-1993, 1995
|
| 11 |
22-44 |
Chronological miscellaneous correspondence,
undated, 1957-1980
|
| 12 |
1-28 |
Chronological miscellaneous correspondence (cont'd),
1981-2008
|
| |
Correspondence of Harry Greenberg and Anthony Kalica,
1976-1983 [subseries]:
|
| 12 |
29 |
Greenberg, Harry correspondence - A-Z by correspondent name,
1976-1983
|
| 12 |
30 |
Kalica, Anthony correspondence - A-Z by correspondent name,
1976-1982
|
| 13 |
1 |
Kalica, Anthony correspondence - A-Z by correspondent name (cont'd),
1976-1982
|
| |
Subjects,
1955-2007 [subseries]:
|
| 13 |
2-5 |
1918 Flu 2005 Avian Flu,
2002-2006
|
| 13 |
6 |
4 New Breast Cancer Genes / DNA Variations for 7 Diseases,
2007
|
| 13 |
7-8 |
Acambis,
1999-2007
|
| 13 |
9 |
Adenovirus and AAV,
1964-2001
|
| 13 |
10 |
Adjuvants for influenza virus vaccines, including use for H5N1 if needed,
2006
|
| 13 |
11 |
Agracetus [photocopy of 1947 article],
undated
|
| 13 |
12-13 |
Albert B. Sabin Vaccine Foundation, Inc.,
1991-1994
|
| 13 |
14-15 |
Anthrax,
1999-2004
|
| 13 |
16 |
Anthrax incidents, hoaxes and threats,
1999
|
| 13 |
17 |
Armed Forces Epidemiological Board (AFEB) - 50th year anniversary,
28 June 1990
|
| 13 |
18-19 |
AFEB Commission on Acute Respiratory Diseases - annual reports,
1969, 2001
|
| 13 |
20 |
AFEB Commission on Influenza - annual report,
1971
|
| 13 |
21 |
Australian National University - annual reports,
1961-1967
|
| 13 |
22-23 |
Avian flu,
2002-2007
|
| 13 |
24 |
Biodefense NIAID,
2002
|
| 13 |
25 |
Bioshield 5105,
2005
|
| 13 |
26 |
Bioterrorist activities - Peter Jahrling, Ph.D. [35mm slides],
29 January 1999
|
| 13 |
27 |
Biowarfare,
1988-1994
|
| 13 |
28 |
Byrne, Robert J., D.V.M. - Deputy Director, Experimental Applications Branch, NIAID,
1979-1980
|
| 13 |
29 |
Chiefs of NIAID [photographs],
2001
|
| 14 |
1 |
Choppin, Purnell,
c.1985
|
| 14 |
2 |
Cold Spring Harbor correspondence,
1986
|
| 14 |
3 |
Conflict of interest issues,
2005
|
| 14 |
4 |
Consultancies - Molecular Vaccines, Inc., and Medimmune,
1988-2002
|
| 14 |
5 |
Dangers of mutants,
1977
|
| 14 |
6 |
Dengue - Jo Blaney,
28 November 2007
|
| 14 |
7 |
Dengue vaccine,
c.1989
|
| 14 |
8 |
Inter-Divisional Vaccine Working Group,
17 September 1993
|
| 14 |
9 |
Edelman memos and correspondence,
1976-1988
|
| 14 |
10 |
Ethics - L.A. Times,
September-October 2004
|
| 14 |
11 |
Executive office NIAID,
1985-1988
|
| 14 |
12 |
Fauci, Dr. Anthony - Director NIAID,
1985-1987
|
| 14 |
13-15 |
Food and Drug Administration (FDA) - Panel on Review of Viral Vaccines and Rickettsial Vaccines,
1975
|
| 14 |
16 |
Freezer repository - inventory contents,
1992
|
| 14 |
17 |
Gallin, Dr. John - Director, Intramural Research Program, NIAID,
1985-1988
|
| |
Goldberg II [subseries]:
Articles sent to Dr. Chanock by journalist Billie Goldberg organized thematically.
|
| 14 |
18 |
Antivirals,
2005
|
| 14 |
19 |
Cancer,
2005
|
| 14 |
20 |
Dengue,
2005
|
| 14 |
21 |
DNA vaccines,
2005
|
| 14 |
22 |
Ebola and Marburg vaccines,
2005
|
| 14 |
23 |
HIV SIV,
2005
|
| 14 |
24 |
Human melanoma virus,
2005
|
| 14 |
25 |
Immunology,
2005
|
| 14 |
26 |
Nobel,
2005
|
| 14 |
27 |
RNAi,
2005
|
| 14 |
28 |
Shingles,
2005
|
| 14 |
29 |
Aviflu,
2006
|
| 14 |
30 |
Biodefense tick borne encephalitis virus,
2006
|
| 14 |
31 |
HIV vaccine,
2006
|
| 14 |
32 |
Important role of inflammation in cardiovascular disease,
2006
|
| 14 |
33 |
Kaposi sarcoma virus receptor,
2006
|
| 14 |
34 |
Old viruses resurrected inhuman DNA,
2006
|
| 14 |
35 |
Osteoporosis protein diabetes genes,
2006
|
| 14 |
36 |
Polio-Weimmer,
2006
|
| 14 |
37 |
Prostate cancer Rx therapy,
2006
|
| 14 |
38 |
RNAi clinical,
2006
|
| 14 |
39 |
Max Theiler 1951,
2006
|
| 14 |
40 |
Vertex HCV,
2006
|
| 14 |
41 |
Vioxx Merck,
2006
|
| 14 |
42 |
West Nile transplant patients,
2006
|
| 14 |
43-44 |
Hartley, Janet,
1981-1994
|
| 14 |
45 |
House hearings on influenza vaccine,
August 1972
|
| 14 |
46 |
Huebner, Robert,
1969-2002
|
| 15 |
1 |
Huebner, Robert (cont'd),
1969-2002
|
| 15 |
2 |
Huebner celebration,
11 November 1999
|
| 15 |
3 |
Hybridon - contract and approval,
1994-1996
|
| 15 |
4 |
ICN Pharmaceuticals,
1990-1991
|
| 15 |
5 |
Infectious Disease Society of America,
1990
|
| 15 |
6 |
Infu H5N1 DOD/NIAID,
2006-2007
|
| 15 |
7 |
Interpretation of serologic reactions in virology - DHEW,
c.1965
|
| 15 |
8-9 |
Intracel,
2000-2001
|
| 15 |
10 |
Intramural Research Program,
1985-1987
|
| 15 |
11 |
Johns Hopkins Society of Scholars,
1999
|
| 15 |
12 |
Kapikian, Albert Z. [photographs],
1984
|
| 15 |
13 |
Krause, Richard M. - Director, NIAID,
1979-1981
|
| 15 |
14 |
Krause, Richard M. (cont'd),
24 March 1995
|
| 15 |
15 |
Laboratory methods in the diagnosis of viral exanthems - DHEW,
c.1965
|
| 15 |
16 |
Laboratory of Viral Diseases - annual report,
1969
|
| 15 |
17 |
Laboratory of Infectious Diseases - history [35mm slides],
1992
|
| 15 |
18 |
Laboratory techniques in virology - DHEW,
c.1965
|
| 15 |
19 |
Mattheis, Martha - Infectious Disease Branch,
1979-1984
|
| |
MedImmune [subseries]:
|
| 15 |
20 |
General,
1998-2005
|
| 15 |
21-25 |
General (cont'd),
1998-2005
|
| 15 |
26 |
Adverse publicity,
1998
|
| 15 |
27 |
Biological materials license agreement,
1996
|
| 15 |
28-38 |
Meetings,
1989-2002
|
| 16 |
1-4 |
Meetings (cont'd),
1989-2002
|
| 16 |
5 |
Sales of Synagis,
January-March 2000
|
| 16 |
6 |
Molecular Vaccines, Inc.,
1988-1989
|
| 16 |
7 |
Monoclonal abs, RSV and otherwise,
1990-1994
|
| 16 |
8-14 |
Morris, Anthony,
1973-1978
|
| 16 |
15-16 |
Mycoplasma pneumonia and others,
1961-2002
|
| 16 |
17-27 |
National Academy of Sciences - Committee on International Security and Arms Control (CISAC),
1988-1997
|
| 17 |
1-8 |
National Academy of Sciences - Committee on International Security and Arms Control (CISAC) (cont'd),
1988-1997
|
| 17 |
9 |
National Academy of Sciences - Sabin, memoirs Rowe,
1998
|
| 17 |
10 |
National Cancer Institute - Frederick Cancer Research Facility Advisory Committee - meeting,
13 February 1987
|
| 17 |
11 |
NIAID Animal Care Committee,
1973-1980
|
| 17 |
12 |
NIAID Biodefense Research Agenda for Category B and C Priority Pathogens - progress report,
2004
|
| 17 |
13-14 |
NIAID Blue Ribbon Panel on Terrorism and its Implications for Biomedical Research,
2002
|
| 17 |
15-16 |
NIAID Clinical Research Subpanel,
1969-1980
|
| 18 |
1 |
NIAID Clinical Research Subpanel (cont'd)
|
| 18 |
2 |
NIAID Committee for Vaccine Development - correspondence,
1962-1967
|
| 18 |
3 |
NIAID Extramural Activities - report,
1968
|
| 18 |
4-6 |
NIAID Intramural Research Program - reports,
1968-1972
|
| 18 |
7 |
NIAID Laboratory Chiefs - meeting minutes,
2002-2005
|
| 18 |
8 |
NIAID Laboratory of Biology of Viruses - annual report,
1968
|
| 18 |
9 |
New York City Department of Health - laboratory analysis of 1957-1958 influenza outbreak in New York City,
1959
|
| 18 |
10-11 |
Pandemic avian flu - Secretary Leavitto's response for greater vaccine production from pharmaceutical manufacturers,
2006
|
| 18 |
12 |
Pandemic flu preparedness,
2001
|
| 18 |
13 |
Papilloma viruses,
c.2000
|
| 18 |
14-15 |
Parainfluenza virus,
1998
|
| 18 |
16 |
Parainfluenza virus / glioma,
2004-2005
|
| 18 |
17 |
Pletnev 5 yr plan,
2004
|
| 18 |
18 |
Pneumonia,
1979
|
| 18 |
19 |
RSV and PIV3 high risk persons: RSV LID,
1991-1992
|
| 18 |
20-21 |
RSV pathogenesis acute and COPD (II),
1993
|
| 18 |
22-26 |
Rowe and Huebner [photographs],
1982-1998
|
| 18 |
27 |
Royal Danish academy of Sciences and letters - elected as foreign member,
1980
|
| 18 |
28-29 |
Russian TBEV collaboration,
2002
|
| 18 |
30-33 |
Sabin, Dr. Albert [photographs],
1964-2006
|
| 19 |
1-7 |
Sabin, Dr. Albert (cont'd),
1964-2006
|
| 19 |
8 |
Sabin poliovaccine [35mm slides],
c.1986
|
| 19 |
9 |
Sabin poliovirus vaccine clinical field trials - final report,
1961
|
| 19 |
10 |
Sabin/Schlesinger dengue,
2003
|
| 19 |
11 |
Scripps Research Institute,
1987-1996
|
| 19 |
12 |
Seasonal and pandemic influenza,
2007
|
| 19 |
13 |
Sell, Kenneth W. - Scientific Director, NIAID,
1978-1984
|
| 19 |
14 |
Small pox,
2001-2006
|
| 19 |
15 |
Smorodintsev adenovirus vaccine,
1969
|
| 19 |
16 |
Society for Pediatric Research,
1993
|
| 19 |
17 |
Sugata, Fumihiko,
1993
|
| 19 |
18 |
Synagis,
1999-2001
|
| 19 |
19 |
Synergistic effect when two disparate mabs are used,
2002-2006
|
| 19 |
20 |
Tyrrell, D. A., Jr.,
1970-1991
|
| 19 |
21 |
U.S. Public Health Service - technical report on Salk poliomyelitis vaccine,
1955
|
| 19 |
22 |
University of British Columbia, Dept. of Microbiology, Div. of Medical Microbiology - annual report,
1971
|
| 19 |
23 |
University of Maryland - prison studies hearing,
3 September 1975
|
| |
Vaccine,
1958-2006 [subseries]:
|
| 19 |
24 |
Adenovirus vaccine program - business case analysis,
c.2006
|
| 19 |
25 |
Vaccine development at the Laboratory of Infectious Diseases,
c.2000
|
| 19 |
26 |
Current status of vaccines for prevention of respiratory syncytial virus infection in infants and children - Peter Wright,
2003
|
| 19 |
27 |
Licensed viral vaccines (U.S.A.),
1988
|
| 19 |
28-29 |
Rotavirus vaccines,
2000-2006
|
| 19 |
30 |
Virology Section - report,
1970
|
| 19 |
31 |
West Nile and Dengue,
2003
|
| 19 |
32 |
World Health Organization (WHO) - viral disease reports,
1958-1971
|
| 19 |
33 |
WHO Expert Advisory Panel on Virus Diseases,
1997
|
| |
Presentations on 35mm Slides,
1961-2005 [subseries]:
|
| 19 |
34 |
Influenza Dearborn TS1[E],
undated
|
| 19 |
35 |
Influenza TS1,
undated
|
| 19 |
36-40 |
Mycoplasma,
undated
|
| 20 |
1-2 |
PI Mpn epidem.,
undated
|
| 20 |
3 |
Poly IC study Knopp,
undated
|
| 20 |
4 |
Respiratory Syncitial,
undated
|
| 20 |
5 |
Respiratory Syncitial Coates,
undated
|
| 20 |
6 |
Smith and Chanock Eaton vol,
undated
|
| 20 |
7 |
Mycoplasma,
1961
|
| 20 |
8 |
Pneumonia,
1961
|
| 20 |
9 |
Respiratory Syncytial Mpn,
1961
|
| 20 |
10 |
Adeno caps PI,
1964
|
| 20 |
11-12 |
Mycoplasma,
c.1965
|
| 20 |
13 |
Respiratory Syncytial and Para,
c.1966
|
| 20 |
14 |
IOM priorities and Respiratory Syncytial Virus,
1966
|
| 20 |
15 |
Mycoplasma,
c.1967
|
| 20 |
16 |
Mycoplasma Boston,
1967
|
| 20 |
17 |
Importance viruses and Mpn respiratory disease,
1968
|
| 20 |
18 |
Respiratory Syncytial temperature sensitive,
1968
|
| 20 |
19 |
Mycoplasma,
1969
|
| 20 |
20 |
Mycoplasma pneumoniae ASM,
1970
|
| 20 |
21 |
Mycoplasma, pneumonia, pap,
1970
|
| 20 |
22 |
PAHO,
December 1970
|
| 20 |
23 |
Flu (temperature sensitive),
1971
|
| 20 |
24 |
Mycoplasma,
1971
|
| 20 |
25 |
Respiratory Syncytial Virus,
1971
|
| 20 |
26 |
Mycoplasma NY Acad.,
January 1973
|
| 20 |
27 |
Respiratory Syncytial,
1973
|
| 20 |
28 |
Animal rights,
c.1979
|
| 20 |
29 |
Rotavirus, dengue, vaccines, etc.,
1980-1981
|
| 20 |
30 |
Long-term goals and strategy of LID research / Sabin polio vaccine,
1986-1988
|
| 20 |
31 |
RSV, dengue, etc.,
c.1989
|
| 20 |
32 |
Respiratory Syncytial,
1989
|
| 20 |
33 |
Respiratory Syncytial Virus chimps and Respiratory Syncytial Virus summaries,
1990
|
| 20 |
34 |
Respiratory Syncytial Virus vaccines,
1990
|
| 20 |
35 |
Rotavirus,
1990
|
| 20 |
36 |
Respiratory Syncytial Virus mabs and fabs,
1990-1995
|
| 20 |
37 |
Respiratory Syncytial Virus,
1991
|
| 20 |
38 |
Respiratory Syncytial Virus,
1992-1993
|
| 20 |
39 |
Respiratory Syncytial Virus (cont'd),
1992-1993
|
| 20 |
40 |
St. Lucia - history of respiratory,
December 2000
|
| 20 |
41 |
Parainfluenza viruses as vectors for the protective antigens of RSV and other respiratory viral antigens,
2004
|
| 20 |
42 |
Reverse genetic studies of the HMPV glycoproteins; Coronavirus vaccines; Respiratory syncytial virus vaccine development,
2005
|
| |
Series 3: Lab Research,
1951-2008 [series]:
|
| |
Lab Notebooks by researcher,
1958-2000 [subseries]:
|
| 21 |
1-2 |
Abinanti, Francis R.,
1958-1964
|
| 21 |
3-19 |
Chanock, Robert M.,
1958-2000
|
| 22 |
1-19 |
Chanock, Robert M. (cont'd),
1958-2000
|
| 23 |
1-19 |
Chanock, Robert M. (cont'd),
1958-2000
|
| 24 |
1-4 |
Chanock, Robert M. (cont'd),
1958-2000
|
| 24 |
5-8 |
Cook, M. Katherine,
1960-1975
|
| 24 |
9 |
Dans, Peter E.,
1966-1967
|
| 24 |
10 |
Forsyth, Ben R.,
1965-1966
|
| 24 |
11-18 |
Hoggan, M. David,
1972-1985
|
| 24 |
19 |
Johnson, Karl M.,
1959-1962
|
| 25 |
1-3 |
Johnson, Karl M. (cont'd),
1959-1962
|
| 25 |
4-8 |
Kapikian, Albert Z.,
1977-1981
|
| 25 |
9-10 |
Lewis, Marianne,
1972-1984
|
| 25 |
11-17 |
Mufson, Maurice A.,
1962-1965
|
| 25 |
18-19 |
Rowe, Wallace P.,
1958-1972
|
| 26 |
1-19 |
Rowe, Wallace P. (cont'd),
1958-1972
|
| 27 |
1-16 |
Rowe, Wallace P. (cont'd),
1958-1972
|
| |
Lab Notebooks by Subject,
1954-1994 [subseries]:
|
| 27 |
17 |
CF Antigens,
1954-1975
|
| 27 |
18 |
Miscellaneous Virus,
1957
|
| 27 |
19 |
Neuraminidase,
1974-1993
|
| 28 |
1-8 |
Neuraminidase (cont'd),
1974-1993
|
| 28 |
9 |
Radioactive Materials,
1971-1974
|
| 28 |
10-16 |
Viral Reagents,
1962-1994
|
| |
Research Data,
1950-2008 [subseries]:
|
| 28 |
17-19 |
Miscellaneous/Unidentified Studies,
undated
|
| 29 |
1-7 |
Miscellaneous/Unidentified Studies (cont'd),
1950-2005
|
| 29 |
8 |
Japanese B encephalitis,
1951-1954
|
| 29 |
9 |
Lab studies on adenovirus, pneumonia or bronchiolites,
1952-1956
|
| 29 |
10 |
Avian Japanese B encephalitis,
1953-1955
|
| 29 |
11 |
Transplacental transmission polio virus,
1954-1955
|
| 29 |
12 |
Polio chick embryo,
1955
|
| 29 |
13 |
Yale - Monkey kidney trypsinization techniques Ph colon test,
1955-1956
|
| 29 |
14 |
Experiment 2. Assay of a high titer phage stock relation of plaque count to volume of phage suspension plated,
1956
|
| 29 |
15 |
Etiology of nonbacterial respiratory disease in infancy and childhood - NIH senior fellowship grant,
1956
|
| 29 |
16 |
Serology,
1956-1957
|
| 69 |
9 |
1 RSV collation,
1956-1957 [RESTRICTED PHI POLICY]
|
| 29 |
17 |
Croup,
1956-1959
|
| 29 |
18 |
Pap virus,
1958-1959
|
| 69 |
11 |
Mycoplasma - U.S. Naval Hospital, Beaufort, S.C. - patient summaries,
1959-1960 [RESTRICTED PHI POLICY]
|
| 29 |
19 |
Respiratory viruses and mycoplasmas clinical: Pap study - Parris Island,
1959-1961
|
| 29 |
20 |
#2 neutralization tests #19,
1959-1998
|
| 29 |
21 |
Immunization,
1961-1962
|
| 69 |
14-15 |
RS vaccine study,
1962-1975 [RESTRICTED PHI POLICY]
|
| 29 |
22 |
Contribution of adenoviruses to respiratory tract illness among children,
1963
|
| 29 |
23 |
Evaluation of WI-26 human diploid fibroblast cultures for isolation of adenovirus type 4,
1963
|
| 29 |
24-25 |
Lots of vaccine - Wyeth,
1963-1968
|
| 29 |
26-27 |
Mycoplasma,
1963-1992
|
| 29 |
28 |
Ludwig adeno capsule,
1964
|
| 29 |
29 |
Respiratory viruses and mycoplasmas clinical: adeno field trials - Parris Island,
1964-1965
|
| 30 |
1 |
Respiratory viruses and mycoplasmas clinical: m. pneumonia trials - Parris Island,
1965-1966
|
| 30 |
2 |
Respiratory viruses and mycoplasmas clinical: rs attenuated strain - 2,
1965-1970
|
| 69 |
18 |
Children's Hospital contract reports,
1965-1981 [RESTRICTED PHI POLICY]
|
| 30 |
3 |
Drug protocols - Wyeth,
1966
|
| 30 |
4 |
Respir. Viruses and mycoplasmas clinical: adeno field trials other,
1966-1967
|
| 69 |
17 |
RS vaccine study,
1967 [RESTRICTED PHI POLICY]
|
| 30 |
5 |
Experimental rubella vaccine lot 12-6/6A,
1967
|
| 30 |
6 |
Myxovirus recovery from respiratory tract illness - summary tables,
1967
|
| 30 |
7 |
Camargo, Ena - RSV - paraflu III plaque,
1967-1972
|
| 30 |
8-13 |
RS vaccine - Children's Hospital of D.C.,
1967-1979
|
| 30 |
14-16 |
Production protocol - adenovirus vaccine, life, oral - type 7 - Wyeth,
1968-69
|
| 30 |
20 |
RS #3 challenge of para 1 new,
November 1970
|
| 30 |
17 |
RS ts 1 mutant - Jessup,
30 December 1969
|
| 30 |
18 |
Clinical research protocols,
1969-1978
|
| 30 |
19 |
RS volunteer - wild type challenge of ts1 vaccinees,
13 February 1970
|
| 30 |
21 |
DBS-IND-294 Wyeth, adenovirus vaccine, type 7, live, oral - book 2,
1970-1972
|
| 30 |
22 |
Antibody response to m. pneumoniae vaccine,
1971
|
| 30 |
23 |
RSV clinical summary - Children's Hospital,
1971
|
| 30 |
24 |
Virus-associated immunopathology animal models and implications for human diseases,
c.1972
|
| 30 |
25 |
RSV primates: to RS in children,
c.1972-1973
|
| 69 |
23 |
Children's Hospital - nasal washings,
1972-1974 [RESTRICTED PHI POLICY]
|
| 30 |
26 |
Lab reports,
1973
|
| 30 |
27 |
Influenza A/1968 (H3N2) virus serum hemagglutination - inhibition antibody status of children before and after the Nov. 1972-Jan. 1973 epidemic of influenza A/1972 (H3N2) in Washington, D.C.,
1973
|
| 30 |
28 |
Clinical observation of infants/children receiving RS-A2, ts-1 mutant,
1973
|
| 30 |
29 |
Mycoplasma vaccine trial (OSU-1) - Naval Medical Field Research Laboratory,
1974
|
| 30 |
30 |
Safety test protocol - A/Georgia/101/74 clone 1B,
1974
|
| 30 |
31 |
RS vaccine summaries - Children's Hospital,
1974-1975
|
| 31 |
1 |
RSV primates: bovine RSV in cotton rats, owl monkeys and chimps,
1974-1993
|
| 31 |
2 |
Swine influenza - Burroughs Wellcome Research Labs,
1975-1979
|
| 31 |
3 |
Camargo, Ena - RSV,
1975-1980
|
| 31 |
4 |
Huebner tumorigenicity TS-1-E (Morris),
1976
|
| 31 |
5 |
Status of two dose trials,
1976
|
| 31 |
6 |
Safety test - parainfluenza virus type 3, strain #22311 (lot F-367),
1976
|
| 31 |
7 |
RSV primates: genetic stability - stress tests RS,
1976-1989
|
| 31 |
8 |
Safety test of influ. A/VIC/3/75 (H3N2) x ts-1 [E], clone 81C1, recomb. virus (code CF/PP/1) - Flow Labs,
1977
|
| 31 |
9 |
Lot F-486 - RSV, strain A2, TS-1 NG-16 mutant,
1977-1979
|
| 31 |
10 |
RSV primates II,
1977-1991
|
| 31 |
11 |
Attenuated influenza vaccines,
1981
|
| 31 |
12 |
Nasal washings - Children's Hospital,
1981
|
| 31 |
13 |
RSV hr mutants in primates ts in primates: guinea pig kidney cell grown RSV - pass 18 chimps,
1981
|
| 31 |
14 |
RSV primates: cotton rat RS,
1981
|
| 31 |
15 |
RSV hr mutants in primates ts in primates: chick lung cell grown RSV passage 6 - chimps,
1982
|
| 31 |
16 |
RSV primates,
1982-1993
|
| 31 |
17 |
Research labs - Merck Sharp and Dohme,
1983-1991
|
| 31 |
18 |
SV40,
1983-2001
|
| 31 |
19-20 |
Production protocols - Wyeth,
1985
|
| 31 |
21 |
RSV hr mutants in primates ts in primates: primates studies RSV,
1986-1990
|
| 31 |
22 |
Immunization: flavi and alpha viruses,
1988
|
| 31 |
23 |
Prophylactic effect antibodies,
18 October 1988
|
| 31 |
24 |
MF59 Chiron,
1989-2006
|
| 31 |
25 |
RSV vaccine testing,
1989-2006
|
| 31 |
26 |
Fourth NIH rotavirus vaccine workshop,
5-6 November 1990
|
| 31 |
27 |
RSV ICN Krugman,
1991-1993
|
| 31 |
28 |
Flavivirus vaccine research - Walter Reed-NIAID,
1991-1994
|
| 31 |
29-30 |
RSV human fob monoclones,
December 1991-February 1995
|
| 31 |
31 |
CA influenza virus - Wyeth,
1992-1993
|
| 31 |
32 |
RSV - Repligen,
1993
|
| 31 |
33 |
Fab 19 MARM,
1993-1995
|
| 31 |
34 |
RSV human FABS,
5 February 1995
|
| 31 |
35-36 |
AGMK cells, karyotype, tumor tests, patent,
1994-2000
|
| 32 |
1-3 |
Bovine RV (4x) clinical trial,
1997
|
| 32 |
4 |
U.S.-Russian collaboration final report,
1997
|
| 32 |
5-7 |
TBEV LGT,
1998-2000
|
| 32 |
8-9 |
TBEV II and West Nile,
2000
|
| 32 |
10 |
History of discovery and development of successful interventions,
2000
|
| 32 |
11 |
West Nile virus,
2000-2006
|
| 32 |
12 |
Periodic dengue, West Nile, TBEV meetings,
2001
|
| 32 |
13-14 |
Dengue vaccine part II,
2001-2007
|
| 33 |
13 |
Dengue virus and West Nile virus,
2008
|
| 32 |
15 |
Dengue virus vaccine development,
2002
|
| 33 |
1 |
TBEV and Langat II,
2002
|
| 33 |
2 |
Dengue virus vaccine data,
2003
|
| 33 |
3 |
Restoration of live adenoviruses vaccine in DOD,
2003-2005
|
| 33 |
4-6 |
Negative SV40,
2004
|
| 33 |
7-8 |
Positive SV40,
2004
|
| 33 |
9 |
Dengue virus vaccine development,
2004
|
| 33 |
10 |
Clinical WN/Den4 serology immunogenicity - clinical Lat/Den4 serology immunogenicity,
2005
|
| 33 |
11 |
Dengue candidates,
August 2006
|
| 33 |
12 |
Den langat,
2006
|
| |
LID Lab Research Reports,
1960-2004 [subseries]:
|
| 33 |
14-27 |
Clinical research projects,
1960-1982
|
| 33 |
28 |
NIAID ad hoc contract review,
1973
|
| 33 |
29 |
Experimental immunoprophylaxis against respiratory syncytial virus infections in primates,
undated
|
| 33 |
30 |
Experimental infection of primates with respiratory syncytial virus,
undated
|
| 33 |
31 |
Histological and virological study of the neurovirulence in rhesus monkeys of a langat/dengue 4 chimeric virus and its parental strains langat virus and dengue type 4 virus,
undated
|
| 33 |
32 |
Virological analyses of recombinant, live, attenuated respiratory syncytial virus subgroup A strain rA2cp248/404/1030ΔSH in healthy unscreened 4-12 weeks old infants,
undated
|
| 33 |
33 |
RNA tumor viruses as etiologic agents of solid tumors as well as leukemia - NIAID/NCI collaborative research,
1968
|
| 33 |
34 |
Determination of the effect of an inducer of interferon (IN-CN) administered to upper respiratory tract on experimentally induced respiratory virus infections,
1969
|
| 33 |
35 |
Safety of cold adapted respiratory syncytial virus vaccine in infants 6-7 months of age,
1969
|
| 33 |
36 |
Serum complement in acute bronchiolitis,
1969
|
| 33 |
37 |
Pediatric adenovirus vaccine evaluations,
1971
|
| 33 |
38 |
Fort Detrick reports,
1972-1977
|
| 34 |
1 |
Chanock scientific studies,
1973-1992
|
| 34 |
2 |
Transferring viruses to NIAID,
1997-1998
|
| 34 |
3 |
Development of a rotavirus vaccine for the prevention of severe rotavirus diarrhea of infants and young children - LID Epidemiology section,
c.2000
|
| 34 |
4-5 |
Development of new approaches for vaccines against the tick-borne encephalitis virus complex - Molecular Viral Biology section,
2000-2001
|
| 34 |
6 |
Phase I study of Ad4-ΔE3-HIVenv and Ad4-ΔE3-HIV/gag/pro recombinant vaccines in HIV-negative volunteers,
2001
|
| 34 |
7 |
Projected schedule for WNV/DEN4 chimera studies,
2001
|
| 34 |
8 |
New molecular approaches to develop live attenuated vaccines against the tick-borne encephalitis complex and the West Nile encephalitis virus,
2003
|
| 34 |
9 |
The development of vaccines for parainfluenza virus types 1, 2, and 3 - Respiratory Viruses section,
2004
|
| 34 |
10 |
In vitro models of paramyxovirus infection,
2004
|
| 34 |
11 |
New molecular approaches to develop live attenuated vaccines against tick-borne encephalitis virus complex and the West Nile and St. Louis encephalitis viruses - Respiratory Viruses section,
2004
|
| 34 |
12 |
NIAID 69-A - Study of non-bacterial respiratory disease A) children,
1966-1969
|
| 34 |
13 |
NIAID 69-B - Non-bacterial respiratory disease in military recruits - epidemiology and experimental immunoprophylaxis,
1966
|
| 34 |
14 |
NIAID 69-C - The etiology of acute respiratory disease in civilian adults,
1965
|
| 34 |
15 |
NIAID 69-D - Collaborative studies of biophysical properties of respiratory viruses which are important to the development of vaccines,
1966
|
| 34 |
16 |
NIAID 70-A - Laboratory studies of newly r4ecognized viruses associated with respiratory illness,
1966
|
| 34 |
17 |
NIAID 70-B - Characterization of newly discovered rhinovirus serotypes of human origin,
1966
|
| 34 |
18 |
NIAID 70-C - Basic studies on mycoplasma,
1966
|
| 34 |
19 |
NIAID 70-C.1 - Serology and seroepidemiology of mycoplasmas (pleuropneumonia-like organisms - PPLO),
1966
|
| 34 |
20 |
NIAID 70-D - Laboratory studies of viral hepatitis agents,
1966
|
| 34 |
21 |
NIAID 70-E - Biological and biophysical studies of rhinoviruses,
1966-1969
|
| 34 |
22 |
NIAID 72-B - Study of respiratory viruses and mycoplasmas in human volunteers,
1969
|
| |
Investigational New Drugs (IND),
1963-2001 [subseries]:
|
| 34 |
23 |
Unnumbered - Attenuated quadrivalent human-bovine (UK) rotavirus reassortant vaccine - original submission,
1995
|
| 34 |
24 |
Unnumbered - Wild-type and attenuated respiratory syncytial viruses; subgroup B,
1993
|
| 34 |
25 |
IND #24 - Parainfluenza type 3 vaccine - suppl. 1-4,
1963-1967
|
| 34 |
26-31 |
IND #71 - Live adenovirus type 4 enteric vaccine - suppl. 31-50,
1967-1972
|
| 34 |
32-35 |
IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24,
1964-1973
|
| 35 |
1-2 |
IND #93 - Parainfluenza virus vaccines (types 1, 2, and 3) - suppl. 1-24 (cont'd),
1964-1973
|
| 35 |
3 |
IND #385 - Monovalent adenovirus type 2 soluble antigen vaccine, aqueous or alum absorbed - suppl. 1, 4-6,
1969-1971
|
| 35 |
4 |
IND #386 - Live, attenuated rubella virus vaccine strain HPV-79-RK 7, lot 31764 - suppl. 2-3,
1969
|
| 35 |
5 |
IND #401 - Meningococcal group C vaccine - suppl. 1-36,
1969-1973
|
| 35 |
6-7 |
IND #419 - Complexed polyinosinic and polycytidylic acids - suppl. 1-13,
1969-1970
|
| 35 |
8-9 |
IND #421 - Parainfluenza 3 challenge pool (attenuated?) - suppl. 1-23,
1969-1973
|
| 35 |
10 |
IND #437 - Pneumococcal polysaccharide vaccines,
1970-1972
|
| 35 |
11 |
IND #450 - Vaccinia virus vaccine -suppl. 7,
1971
|
| 35 |
12 |
IND #582 - H. Influenzae type b PRP vaccine - suppl. 10, 188,
1972-1987
|
| 35 |
13-20 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399,
1972-1995
|
| 36 |
1-17 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 37 |
1-18 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 38 |
1-18 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 39 |
1-18 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 40 |
1-18 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 41 |
1-3 |
IND #601 - Live, attenuated influenza A virus (H3N2) vaccines (ts mutants and recombinants of them) - suppl. 1-399 (cont'd),
1972-1995
|
| 41 |
4-5 |
IND #734 - TS mutants of mycoplasma pneumoniae - suppl. 1-1C (inactive),
1974-1977
|
| 41 |
6 |
IND #735 - Inactivated monovalent influenza B virus vaccine,
1973
|
| 41 |
7-8 |
IND #825 - Inactivated influenza A virus vaccines subunit - suppl. 1-30,
1974-1980
|
| 41 |
9 |
IND #839 - Poly I; poly C: poly-l-lysine - suppl. 1,
1974
|
| 41 |
10 |
IND #1044 - Live parainfluenza virus vaccines types 1, 2, and 3, placebo - suppl. 1-8 (inactive),
1975-1978
|
| 41 |
11-19 |
IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51,
1976-1980
|
| 42 |
1-6 |
IND #1115 - Inactivated influenza A virus vaccines QA/NJ/1976 - suppl. 1-51 (cont'd),
1976-1980
|
| 42 |
7 |
IND #1287 - Adenovirus subunit vaccines - suppl. 1-11,
1978-1982
|
| 42 |
8-17 |
IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118,
1978-1990
|
| 43 |
1-17 |
IND #1298 - Inactivated influenza A virus vaccines (H1N1) - suppl. 1-118 (cont'd),
1978-1990
|
| 43 |
18 |
IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37,
1979-1993
|
| 44 |
1-5 |
IND #1384 - Live attenuated respiratory syncytial virus vaccine - suppl. 1-29, 37 (cont'd),
1979-1993
|
| 44 |
6 |
IND #1462 - Varicella virus vaccine - suppl. 123,
1987
|
| 44 |
7-20 |
IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139,
1980-1998
|
| 45 |
1-15 |
IND #1530 - Live human rotavirus (Wa strain, subgroup 2 [formerly type 2]) vaccine candidate - suppl. 1-125, 139 (cont'd),
1980-1998
|
| 45 |
16 |
IND #1808 - E. coli CFA/II pili vaccine oral - suppl. 4,
1985
|
| 45 |
17 |
IND #1914 - Interferons - suppl. 9-10,
1985
|
| 45 |
18 |
IND #2000 - Vi capsular antigen - suppl. 4,
1985
|
| 45 |
19-21 |
IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63,
1988-1995
|
| 46 |
1-7 |
IND #2843 - Live attenuated parainfluenza virus vaccines - supple 1-63 (cont'd),
1988-1995
|
| 46 |
8-10 |
IND #2858 - Bovine parainfluenza virus type 3 - suppl. 1-30,
1988-1994
|
| 46 |
11-14 |
IND #4006 - Rhesus rotavirus vaccines, live, (tetravalent, serotypes 1, 2, 3, and 4) oral - suppl. 1-25,
1988-1998
|
| 46 |
15-19 |
IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58,
1993-2000
|
| 47 |
1-5 |
IND #4942 - Wild-type and attenuated respiratory syncytial viruses; subgroup A - suppl. 1-58 (cont'd),
1993-2000
|
| 47 |
6-9 |
IND #4981 - Respiratory syncytial virus subgroup B (strain 14617, vero 1 cells) wild type and attenuated live vaccines - suppl. 1-33,
1993-2000
|
| 47 |
10 |
IND #7762 - Respiratory syncytial virus, live, attenuated vaccine and purified fusion protein with alum - suppl. 1-6, 8-9,
1998-2001
|
| |
Research Contracts,
1952-2001 [subseries]:
|
| |
Proposals,
1955-2001 [subseries]:
|
| 47 |
11 |
Unidentified,
undated
|
| 47 |
12 |
Etiology of viral diarrheas - part III,
undated
|
| 47 |
13 |
To obtain a recombinant form of type 1 poliomyelitis virus capable of multiplication in the embryonated egg,
1955
|
| 47 |
14 |
Assess antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . .,
c.1964
|
| 47 |
15 |
The isolation of viruses and viral subunits,
1964
|
| 47 |
16 |
Respiratory syncytial virus vaccine concentrated 100-fold from monkey kidney tissue cultures,
c.1965
|
| 47 |
17 |
Studies on adenovirus vaccines,
c.1965
|
| 47 |
18 |
Biochemical and immunologic investigations of neisseria meningitidis,
1965
|
| 47 |
19 |
Development of prototype, inactivated vaccines for respiratory syncytial and parainfluenza viruses and for mycoplasma pneumoniae,
1965
|
| 47 |
20 |
To assess the antigenicity and effectiveness in infants and children of vaccines against newly discovered viruses responsible for respiratory tract illness. . .,
1965
|
| 47 |
21 |
Concentration of human hepatitis virus (supplement to NIAID Support of Man program),
1966
|
| 47 |
22 |
Proposed vaccine studies, Kansas City,
1966
|
| 47 |
23 |
Respiratory virus vaccines,
1967
|
| 47 |
24 |
Tests in infants and children for antigenicity and effectiveness of inactivated vaccines,
1967
|
| 47 |
25 |
X-ray crystal structure of adenovirus coat protein,
1969
|
| 47 |
26 |
Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children,
1971
|
| 47 |
27 |
Studies on hemophilus influenzae b vaccine,
c.1972
|
| 47 |
28 |
Specific cell-mediated immunity to respiratory syncytial virus in infants and children following natural infection or immunization,
1974
|
| 47 |
29 |
Hybridization of highly radioactive adenovirus DNA strands with cancer DNA to detect viral DNA copies in human cancer cells,
1975
|
| 47 |
30 |
Evaluation of skin test reactivity during wild type and temperature sensitive influenza virus infection,
1975
|
| 47 |
31 |
Protective efficacy of langat virus vaccines in mice - animal study proposal,
1997
|
| 47 |
32 |
Evaluation of protective efficacy of dengue vaccines in mice - animal study proposal,
1999
|
| 47 |
33 |
Evaluation of chimeric TBEV/DEN4 virus vaccines in mice,
2001
|
| 47 |
34 |
Immunogenicity and protective efficacy of langat virus vaccines in mice,
2001
|
| |
Reports,
1952-1998 [subseries]:
|
| 47 |
35-39 |
National Foundation for Infantile Paralysis - Children's Hospital, Cincinnati,
1952-1956
|
| 47 |
40 |
Vaccine development program commitments,
1965
|
| 47 |
41 |
Respiratory vaccine development,
1966
|
| 47 |
42 |
Induced upper respiratory tract infection of man with living adenovirus vaccine type 4, study #1, Lorton Reformatory,
1967
|
| 47 |
43 |
NIAID Molecular Anatomy Program,
1967
|
| 47 |
44 |
Evaluation of a live type 4 adenovirus vaccine,
1967-1968
|
| 47 |
45 |
Acute infectious nonbacterial gastroenteritis,
1973
|
| 47 |
46 |
103, 1169, 943 - Tissue culture and serology oncogenicity studies, RSV studies,
1964-1965
|
| 47 |
47 |
6-61-03-032 - Studies on virus and rickettsial diseases,
1953
|
| 47 |
48 |
263-81-C-0295 - Providing lung tissue, blood samples and nasal secretions,
1981
|
| 47 |
49 |
263-82-C-0037 - Providing lung tissue, blood samples and nasal secretions,
1981
|
| 47 |
50 |
3A014501B71Q - Communicable diseases - immunology,
c.1966
|
| 47 |
51 |
DA-49-007-MD-950 - Comparison of aqueous and adjuvant adenovirus vaccines,
1963
|
| 47 |
52 |
DA-49-193-MD-2131 - Purification, characterization and synthesis of components of adenovirus,
1965
|
| 47 |
53 |
DA-49-193-MD-2189 - Studies on the etiology and epidemiology of acute respiratory infections,
1965
|
| 47 |
54 |
DA-49-193-MD-2495 - Genetic relationships among human and animal strains of influenza virus,
1967
|
| 47 |
55 |
DA-49-193-MD-2795 - Recombination and transmission studies with influenza virus,
1971
|
| 47 |
56 |
DADA-17-70-C-0121 - Purification, characterization, and synthesis of components of adenovirus,
1971
|
| 47 |
57 |
M4305.01-1011 BFG6; M4305.01-1012 BFG6 - Epidemiology and prevention fo acute respiratory disease in navy recruits,
1972
|
| 48 |
1 |
NIH-69-91 - Laboratory and antigenic studies of RSV; evaluation of respiratory syncytial, mimingococccal, and pneumococcal polysaccharide vaccines,
1970
|
| 48 |
2 |
NIH-69-2072 - Research and development of adenovirus vaccines and parainfluenza virus vaccines,
1970
|
| 48 |
3 |
NIH-69-2109 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness,
1969
|
| 48 |
4 |
NIH-71-2091 - The assessment of antigenicity and effectiveness of respiratory disease vaccines,
1971
|
| 48 |
5-6 |
NIH-71-2196 - Respiratory viral vaccines and pathogenesis of respiratory viral disease in infants and children,
1971, 1973
|
| 48 |
7 |
N01-AI-01528 - New viruses in relation to clinical diseases,
1968-1972
|
| 48 |
8-9 |
N01-AI-02638 - Operation of a virus vaccine production laboratory,
1980-1981, 1983-1987
|
| 48 |
10 |
N01-AI-02653 - Center for the clinical testing of bacterial vaccines, respiratory virus vaccines and antivirals,
1981
|
| 48 |
11-13 |
N01-AI-05057 - University of Puerto Rico,
1991-1992
|
| 48 |
14-15 |
N01-AI-05067 - Care and housing of AIDS research animals,
1990-1991
|
| 48 |
16 |
N01-AI-17757 - Children's Hospital,
1980-1981
|
| 48 |
17-19 |
N01-AI-22503 - Clinical evaluation of respiratory viral and bacterial vaccines in children and adults,
1972-1989
|
| 48 |
20 |
N01-AI-22504 - Development of attenuated mutants of respiratory syncytial virus and parainfluenza viruses as potential vaccine strains,
1974
|
| 48 |
21 |
N01-AI-22508 - Clinical evaluation of influenza virus vaccines,
1974
|
| 48 |
22 |
N01-AI-35154 - Protocol relating to the passage, history, production, safety testing and characterization of an experimental live virus vaccine pool of influenza A/Beijing/352/89 (H3N2) . . .,
1993-1994
|
| 49 |
1-2 |
N01-AI-32521 - Operation of a virus laboratory in support of LID,
1974-1990
|
| 49 |
3-4 |
N01-AI-42510 - Preparation of isolated hemagglutinin, neuraminidase, matrix, and nucleoprotein subunits of influenza viruses and assay of their immunogenicity,
1978
|
| 49 |
5 |
N01-AI-42528 - Influenza research center,
1979
|
| 49 |
6 |
N01-AI-52565,
1985-1987
|
| 49 |
7-8 |
N01-AI-72535 - Establishment of an infectious enteric disease study,
1978-1979
|
| 49 |
9-10 |
N01-AI-82681 - Operation of an experimental virus vaccine production laboratory,
1988-1989
|
| 49 |
11 |
N01-AO-52703 - Care and housing of AIDS research animals,
1997-1998
|
| 49 |
12 |
N01-AO-52706 - Facility for non-human primates utilized in infectious disease research,
1998
|
| 49 |
13 |
PH-40-30-64 - Development of a technique for virus and viral subunit isolation from large volumes of tissue culture,
1966
|
| 49 |
14 |
PH-43-62-80 - Production of enterovirus antisera,
1965
|
| 49 |
15 |
PH-43-62-127 - Preparation of immune serum to enteroviruses,
1965
|
| 49 |
16 |
PH-43-62-129 - Standardization of picornavirus immune sera,
1965
|
| 49 |
17-26 |
PH-43-62-473; PH-43-66-917 - Antigenicity and protection studies on inactivated 100X concentrated RSV vaccine and inactivated 100X concentrated parainfluenza 1 virus vaccine,
1962-1970
|
| 49 |
27-29 |
PH-43-62-477 - Respiratory virus vaccine evaluation and surveillance,
1966-1968
|
| 49 |
30-32 |
PH-43-62-487 - Research and development of rhinovirus, mycoplasma pneumoniae, and RS vaccines,
1966-1968
|
| 49 |
33 |
PH-43-62-839 - Preparation of mycoplasma antigene and antisera,
1965
|
| 49 |
34-35 |
PH-43-63-75 - Respiratory disease surveillance and vaccine studies in military dependent children,
1968, 1970
|
| 49 |
36-38 |
PH-43-63-76 - Viral respiratory disease and immune response in the aged and in a pediatric population,
1966-1968
|
| 50 |
1-4 |
PH-43-63-79 - Research and development of adenovirus vaccines and parainfluenza virus vaccines and adaptation of RSV to embryonated eggs of several avian species,
1964-1966
|
| 50 |
5-6 |
PH-43-63-80 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illnesses,
1965, 1967
|
| 50 |
7 |
PH-43-63-81 - Development, growth and characterization of virus induced tumor cells,
1967
|
| 50 |
8 |
PH-43-63-90 - Upper respiratory virus,
1965
|
| 50 |
9 |
PH-43-63-103 - Operation of a serology and tissue culture developmental laboratory,
1966
|
| 50 |
10-11 |
PH-43-63-562 - Prevention of viral respiratory infections,
1964, 1968
|
| 50 |
12 |
PH-43-63-563 - Vaccine studies in a children's center,
1968
|
| 50 |
13 |
PH-43-63-564 - Research on attenuation of rhinoviruses and methods for measuring antibody response to rhinovirus infection,
1967
|
| 50 |
14-16 |
PH-43-63-582 - Respiratory disease vaccine,
1962-1967
|
| 50 |
17-18 |
PH-43-63-1128 - Surveillance of respiratory infections in an industrial population,
1966, 1968
|
| 50 |
19-20 |
PH-43-63-1141 - Surveillance of viral respiratory diseases and vaccine evaluation in a pediatric population,
1967-1968
|
| 50 |
21 |
PH-43-63-1163 - Studies on the response of primates to respiratory syncytial virus,
1964
|
| 50 |
22 |
PH-43-63-1174 - World Health Organization Reference Centre for Enteroviruses,
1965
|
| 50 |
23 |
PH-43-63-1177 - Reference seeds for echo and coxsackieviruses,
1965
|
| 50 |
24 |
PH-43-64-529 - Preparation and development of viral reagents,
1965
|
| 50 |
25-27 |
PH-43-64-928 - Molecular structure of oncogenic and non-oncogenic adenoviruses and the mechanism of viral carcinogenesis,
1966, 1968, 1972
|
| 50 |
28-29 |
PH-43-64-943 - Developmental study relating to the preparation of a respiratory syncytial virus vaccine,
1966-1967
|
| 50 |
30-32 |
PH-43-64-1169 - Oncogenicity testing of candidate viral respiratory vaccine strains and tumor reagent programs,
1965-1967
|
| 50 |
33-34 |
PH-43-65-562 - Rhinovirus reference laboratory,
1966-1967
|
| 50 |
35-36 |
PH-43-65-563 - Studies of RSV vaccines,
1966-1967
|
| 50 |
37 |
PH-43-65-1004 - Characterization and propagation of live rubella vaccine candidate strains and production reagents,
1968
|
| 50 |
38-40 |
PH-43-65-1031 - Study of vaccines for immunization against viral respiratory infections,
1966-1968
|
| 50 |
41 |
PH-43-66-63 - The testing of experimental respiratory agents and vaccines in volunteers,
1966
|
| 50 |
42-43 |
PH-43-66-93 - Rubella vaccine development,
1967-1968
|
| 50 |
44 |
PH-43-66-99 - Research on the feasibility of preparing inactivated and/or attenuated rubella virus vaccines,
1967
|
| 50 |
45 |
PH-43-66-459 - Research and development of attenuated and inactivated rubella vaccines,
1968
|
| 50 |
46-47 |
PH-43-66-461 - Research and development of an inactivated rubella virus vaccine,
1967-1968
|
| 50 |
48 |
PH-43-66-462 - Epidemiology of respiratory disease in total natural community and evaluation of immunizing agents,
1966
|
| 50 |
49 |
PH-43-66-464 - Studies on the detection of rubella virus and its immunogenicity for animals and man,
1966-1968
|
| 50 |
50 |
PH-43-66-565 - Development of a live vaccine for human influenza,
1966
|
| 50 |
51-52 |
PH-43-66-917 - The role of infection in precipitating sudden deaths in infants,
1969
|
| 50 |
53-54 |
PH-43-66-951 - Maintenance of a marmoset colony under strict isolation conditions,
1967-1968
|
| 50 |
55 |
PH-43-66-970 - Operation of a tissue culture developmental laboratory,
1967
|
| 50 |
56 |
PH-43-66-971 - Provide for the operation of a serology laboratory,
1967
|
| 50 |
57-58 |
PH-43-67-48 - Longitudinal studies of acute respiratory diseases in children,
1968, 1970
|
| 50 |
59-60 |
PH-43-67-75 - The testing of rubella virus vaccines in human volunteers,
1967-1968
|
| 50 |
61 |
PH-43-67-76 - Identification, characterization, purification and concentration of the antigens of respiratory syncytial virus,
1968
|
| 50 |
62 |
PH-43-67-77 - Biologic and antigenic studies with rubella virus,
1968
|
| 50 |
63 |
PH-43-67-78 - The influence of cultural conditions and concentration procedures on the antigenicity of mycoplasma pneumoniae vaccines,
1968
|
| 50 |
64-65 |
PH-43-67-79 - Study of the antigenicity and immunogenicity of mycoplasma pneumoniae vaccines,
1967
|
| 50 |
66 |
PH-43-67-80 - Studies of rubella vaccine efficacy,
1967
|
| 50 |
67 |
PH-43-67-91 - Research and development of respiratory disease vaccines,
1967-1968
|
| 50 |
68 |
PH-43-67-681 - Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines,
1973
|
| 50 |
69 |
PH-43-67-692 - Search for virus-specific genetic material in human cancers and studies on the mechanism of viral carcinogenesis,
1969
|
| 50 |
70-71 |
PH-43-67-745 - Studies of local antibody in respiratory viral immunity,
1967, 1969
|
| 50 |
72 |
PH-43-68-81 - Operation of a rubella virus service laboratory,
1968
|
| 50 |
73 |
PH-43-68-83 - Primary immunization of infants with group A streptococcal M protein,
1968
|
| 50 |
74 |
PH-43-68-692 - Research and development of rhinovirus and mycoplasma pneumoniae vaccines,
1968
|
| 51 |
1-4 |
PH-43-68-1309 - Development of chemically induced conditional-lethal temperature-sensitive (ts) mutants of RS and parainfluenza viruses,
1968-1975
|
| 51 |
5-6 |
PH-43-68-1316 - To develop improved polyvalent adenovirus vaccine to provide a base for others against viral agents in respiratory illness,
1968-1969
|
| 51 |
7 |
Z01-AI-00024 - Laboratory studies of myxoviruses, paramyxoviruses and respiratory syncytial virus,
1977
|
| 51 |
8 |
Z01-AI-00175 - Laboratory studies of paramyxoviruses and respiratory snycytial virus,
1978-1981
|
| |
Cooperative Research and Development Agreements (CRADA),
1972-2003 [subseries]:
|
| 51 |
9 |
License agreements,
1988-1996
|
| 51 |
10-11 |
Chiron,
1988-2003
|
| 51 |
12-15 |
Intracel,
1995-1997
|
| 51 |
16-21 |
Lederle,
1992-2000
|
| 52 |
1-10 |
Lederle (cont'd),
1992-2000
|
| 52 |
11 |
MedImmune,
2002
|
| 52 |
12 |
Praxis,
1987-1988
|
| 52 |
13 |
Upjohn,
1988
|
| 52 |
14-27 |
Wyeth,
1972-2001
|
| 53 |
1-5 |
Wyeth (cont'd),
1972-2001
|
| |
Series 4: Patents,
1966-2008 [series]:
|
| 53 |
6-7 |
Chanock's patents,
1967-2000
|
| 53 |
8-10 |
Patent status reports,
2002-2008
|
| 53 |
11 |
Confluent growth of mycoplasma - application,
1966-1967
|
| 53 |
12-15 |
#3,317,393 - Immunization by selective infection of the intestinal tract with an encapsulated live virus,
1967-2005
|
| 53 |
16-17 |
#3,992,522 - Temperature sensitive recombinant mutant viruses and a process for producing same,
1974-1976
|
| 53 |
18 |
#4,552,757 - Use in an animal host and precursors for vaccines utilizing avian-human reassortants to combat influenza A virus,
1984-1988
|
| 53 |
19-20 |
#4,571,385 - Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors,
1995-1999
|
| 53 |
21-29 |
#4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth),
1998-2005
|
| 54 |
1-4 |
#4,704,275 - Vaccine against rotavirus diseases (RotaShield - RRV-TV - Wyeth) (cont'd),
1998-2005
|
| 54 |
5 |
#4,751,080 - Vaccine against rotavirus diseases,
1988
|
| 54 |
6-9 |
#4,800,078 - Immunotherapeutic method of treating respiratory disease by intranasal administration of IGB,
1966-1993
|
| 54 |
10 |
#5,646,033 - African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines,
1997
|
| 54 |
11-18 |
#5,762,905 - Human neutralizing monoclonal antibodies to respiratory syncytial virus,
1995-2004
|
| 54 |
19 |
#5,882,651 - Attenuated respiratory syncytial virus vaccine compositions,
1993
|
| 54 |
20 |
#5,911,998 - Method of producing a virus vaccine from an African green monkey kidney cell line,
1999
|
| 54 |
21 |
#5,922,326 - Attenuated respiratory snycytial virus vaccine compositions,
1993
|
| 54 |
22 |
#6,117,667 - Method for producing an adapted virus population from an African green monkey kidney cell line,
2000
|
| 54 |
23-33 |
#6,184,024 - Chimeric and/or growth restricted flaviviruses,
1992-2007
|
| 55 |
1-2 |
#6,184,024 - Chimeric and/or growth restricted flaviviruses (cont'd),
1992-2007
|
| 55 |
3-9 |
#6,497,884 - Chimeric vaccine against tick-borne encephalitis virus,
2000-2007
|
| 55 |
10 |
#6,660,273 - Chimeric vaccine against tick-borne encephalitis virus,
2003
|
| 55 |
11-12 |
#6,676,936 - Chimeric and/or growth-restricted flaviviruses,
1998-1999
|
| 55 |
13-19 |
#6,794,174 - Full-length infectious cDNA clones of tick-borne flavivirus,
2001-2008
|
| 55 |
20 |
#7,150,984 - Attenuated human rotavirus vaccine,
2006
|
| 55 |
21 |
#7,364,737 - Human neutralizing monoclonal antibodies to respiratory syncytial virus,
2008
|
| 55 |
22-25 |
#7,932,074 - Multivalent human-bovine rotavirus vaccine,
1998-2006
|
| 55 |
26-28 |
#8,778,671 - Construction of West Nile virus and dengue fever chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus,
2001-2004
|
| |
Series 5: Writings/Reprints,
1953-2007 [series]:
|
| 55 |
29 |
Chanock numbered bibliography (1-653),
2003
|
| |
Numbered Articles by Dr. Chanock,
1953-2003 [subseries]:
|
| 55 |
30-34 |
1-5,
1953-1954
|
| 56 |
1-144 |
6-151 [incomplete],
1954-1967
[missing 127, 149]
|
| 57 |
1-148 |
152-323 [incomplete],
1967-1976
[missing 169, 194, 200, 203, 209, 219, 221, 230, 236, 247, 250, 252-253, 257, 259, 290, 291, 293-295, 301, 310, 315, 319]
|
| 58 |
1-194 |
325-568 [incomplete],
1976-1989
[missing 330, 340, 342, 348, 350, 364, 370, 384, 396, 411, 443-444, 449-450, 460, 464-465, 467, 470, 471, 474-477, 479, 481-482, 502-503, 505, 509, 524-525, 527, 532, 534, 537, 540-542, 546, 551-552, 557-558, 560, 563-566]
|
| 59 |
1-46 |
570-653 [incomplete],
1989-2003
[missing 574, 576, 579-581, 584, 586, 589-594, 597-600, 602, 605, 608, 611-612, 615, 618, 620-623, 625, 629-630, 641-644, 647-649]
|
| |
Unnumbered Reprints by Dr. Chanock,
1954-2005 [subseries]:
|
| 59 |
47 |
Respiratory syncytial vaccine - with Murphy, Collins, and Olmsted,
undated
|
| 59 |
48 |
Recovery and characterization of hemagglutinins from two immunologically distinct types of dengue virus - with Sabin and Sweet,
c.1954
|
| 59 |
49 |
III. Production of illness and clinical observations in adult volunteers,
1961
|
| 59 |
50 |
Primary atypical pneumonia,
1966
|
| 59 |
51 |
Genetic approaches to the prevention of influenza A virus infection - with Murphy,
1981
|
| 59 |
52 |
Strain-specific serum antibody response in infants undergoing primary infection with respiratory syncytial virus - with Hendry, Burns, Walsh, Graham, Wright, Hemming, Rodriguez, Kim, Prince, McIntosh, and Murphy,
1988
|
| 59 |
53 |
Antigenic analysis of the dengue virus envelope glycoprotein using synthetic peptides - with Markoff, Bray, Lai, Eckels, Summers, Gentry, Houghten, and Lerner,
1988
|
| 59 |
54 |
Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev,
2005
|
| |
Drafts by Dr. Chanock,
c.1960s-c.2007 [subseries]:
|
| 59 |
55 |
Untitled fragments,
undated
|
| 59 |
56 |
Acute respiratory disease of infancy and childhood - present understanding and prospects for prevention,
undated
|
| 59 |
57 |
Blueprint for use of live virus vaccine to prevent a pandemic of influenza A virus - with Murphy and Spring,
undated
|
| 59 |
58 |
Decreased virulence and protective effect of a genetically stable temperature-sensitive mutant of m. pneumoniae in human volunteers,
undated
|
| 59 |
59 |
Infection of immature white mice by the addition of western equine encephalitis virus to the feed,
undated
|
| 59 |
60 |
Parainfluenza, respiratory syncytial, and New Castle disease viruses - with Parrott (title page only),
undated
|
| 59 |
61 |
Development of immunity - outline,
c.1960s
|
| 59 |
62 |
Prospects for control of auto viral mycoplasmal respiratory tract disease by vaccination,
c.1960s
|
| 59 |
63 |
Untitled draft re pediatric respiratory illnesses at Camp Lejeune 1959-1963,
c.1964
|
| 59 |
64 |
The contribution of adenoviruses to respiratory tract illness among children,
c.1965
|
| 59 |
65 |
The relationship of mycoplasma pneumoniae to pediatric respiratory tract disease - with Canchola, Brandt, Kim, and Parrott,
1970
|
| 59 |
66 |
Guide for the collection and transport of virological specimens,
1975
|
| 59 |
67 |
Virus and mycoplasma pneumoniae in respiratory disease patients, January 1975-June 1976 - with Brandt, Kim, Arrobio, and Parrott,
c.1977
|
| 59 |
68 |
Isolation and characterization of temperature-sensitive mutants of influenza A virus,
1977
|
| 59 |
69 |
Bovine respiratory syncytial virus: studies in experimental animals - with Prince, Suffin, Horswood, Camargo, Prevar, and Sly,
1980
|
| 59 |
70 |
Respiratory syncytial virus in cotton rats: growth, antigenicity and protective efficacy of two temperature-sensitive, live virus vaccine candidates, ts-1-NG-1 and ts-1-NG-16 - with Prince, Horswood, Prevar, Camargo, Suffin, and Spring,
1980
|
| 59 |
71 |
HLA antigens in severe respiratory syncytial virus disease in infants and early childhood - with Johnson, Kiim, Hartzman, Parrott, Woody, and Sell,
1981
|
| 59 |
72 |
Studies of avian-human reassortant influenza A viruses in seronegative (HAE<1:8) adult volunteers, 1984-86 - with Clements, Murphy, Snyder, Buckler-White, Tierney, Betts, Dolin, Black, and Sears,
1986
|
| 59 |
73 |
Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations,
1991
|
| 59 |
74 |
A live cold-passaged temperature-sensitive mutant of human respiratory syncytial virus is highly attenuated, genetically stable, immunogenic, and efficacious against wild type challenge in seronegative chimpanzees,
1993
|
| 59 |
75 |
"Cold-passaged and temperature sensitive (ts) derivatives of the partially attenuated respiratory syncytial virus ts-4 mutant are more restricted in replication in mice - with Crowe, Jr., Hsu, Lubeck, and Murphy,
c.1994
|
| 59 |
76 |
Short summary of studies of chimeric viruses as candidates for live attenuated vaccine against tick-borne encephalitis,
2000-2005
|
| 59 |
77 |
Comparison of live and inactivated tick-borne encephalitis virus vaccines for immunogenicity and efficacy in rhesus monkeys - with Rumyantsev, Murphy, and Pletnev,
2005
|
| 59 |
78 |
Early experiences with influenza adjuvated vaccines,
c.2007
|
| |
Untitled Drafts by Dr. Chanock,
c.1955-c.2007 [subseries]:
|
| 59 |
79 |
Miscellaneous individual pages,
undated
|
| 59 |
80 |
The interplay of immunologic factors in acute viral respiratory tract disease,
undated
|
| 59 |
81 |
pages 16-22 re ts mutants,
undated
|
| 59 |
82 |
There is compelling evidence that local immunity plays a major role in resistance to most respiratory viral pathogens,
undated
|
| 59 |
83 |
re temperature-sensitive mutants,
undated
|
| 59 |
84 |
re vaccines against RSV,
undated
|
| 59 |
85 |
re arthropod-borne encephalitis viruses,
c.1955
|
| 59 |
86 |
pages 3-15 re RS virus,
c.1962
|
| 59 |
87 |
report on tests of inactivated respiratory virus vaccines,
c.1967-1968
|
| 59 |
88 |
mycoplasma pneumoniae,
1973
|
| 59 |
89 |
RS virus (RSV) is the major viral pathogen of the respiratory tract,
1975
|
| 59 |
90 |
Respiratory syncytial (RS) virus is the major etiologic agent of bronchiolitis,
1976
|
| 59 |
91 |
pages 25-90 of "f-rot.doc",
1989
|
| 59 |
92 |
Evaluation of antibody response to RSV,
1990
|
| 59 |
93 |
pages 9-29 re serum RSV antibodies,
c.1994
|
| 59 |
94 |
re vaccine against TBEV,
c.2002
|
| 59 |
95 |
re Langat virus (LGT) - with Kyle,
2002
|
| 59 |
96 |
re flaviviridae tick-borne encephalitis viruses (TBEV),
2004
|
| 59 |
97 |
re protective immune response against 1918 influenza virus,
c.2007
|
| |
Books Inscribed to Dr. Chanock,
1998-2004 [subseries]:
|
| 60 |
1 |
Textbook of Military Medicine - Part I Warfare, Weaponry and the Casualty,
1998
|
| 60 |
2 |
Hantavirus hunting - by Ho-Wang Lee,
2004
|
| |
Series 6: Meetings,
1954-2005 [series]:
|
| 60 |
3 |
Proceedings of the Conference on Complement Fixation,
5 August 1954
|
| 60 |
4-5 |
Proceedings of the Conference on Neutralization,
18-20 May 1955
|
| 60 |
6 |
Proceedings of the Round Table Conference on Genetic Aspects of Virus-Host Cell Relationships with Particular Reference to Polioviruses,
23-24 February 1956
|
| 60 |
7 |
Society for Pediatric Research annual meeting,
8-9 May 1959
|
| 60 |
8 |
Meetings - general,
1960
|
| 60 |
9 |
Meetings - general,
1961
|
| 60 |
10-11 |
Russian trip,
May 1961
|
| 60 |
12 |
Meeting in Prague, Czechoslovakia,
23-27 May 1961
|
| 60 |
13 |
World Health Organization, Geneva,
15-21 August 1961
|
| 60 |
14 |
Meetings - general,
1962
|
| 60 |
15 |
International Postgraduate Course Respiratory Virus Diseases,
11-14 April 1962
|
| 60 |
16 |
Newer Respiratory Disease Viruses,
3 October 1962
|
| 60 |
17 |
Meetings - general,
1963
|
| 60 |
18 |
World Health Organization Respiratory Virus meeting,
1-6 July 1963
|
| 60 |
19 |
University of Wisconsin Symposium on New Castle Disease,
15 July 1963
|
| 60 |
20 |
7th International Congress on Tropical Medicine,
1-11 September 1963
|
| 60 |
21 |
Seminar on Respiratory Disease,
9 October 1963
|
| 60 |
22 |
Meetings - general,
1964
|
| 60 |
23 |
American College of Physicians,
6-10 April 1964
|
| 60 |
24 |
World Health Organization directors,
20-27 July 1964
|
| 60 |
25 |
Meetings - general,
1965
|
| 60 |
26 |
Rhinovirus workshop,
25 January 1965
|
| 60 |
27 |
American Society of Clinical Investigation,
3 May 1965
|
| 60 |
28 |
World Health Organization,
27 September 1965
|
| 60 |
29 |
Armed Forces Epidemiological Board Commission on Viral Infections,
14-15 October 1965
|
| 60 |
30 |
International Congress of Pediatrics,
7 November 1965
|
| 60 |
31 |
Conference on Acute Infectioius Respiratory Diseases,
14-15 December 1965
|
| 60 |
32 |
Meetings - general,
1966
|
| 60 |
33 |
Mycoplasma conference,
9-11 February 1966
|
| 60 |
34 |
American Society for Clinical Investigation,
1 May 1966
|
| 60 |
35 |
New York Academy of Science,
11 May 1966
|
| 60 |
36 |
Conference on Live Oral Adenovirus Vaccine in Marine and Navy Recruits,
10-11 June 1966
|
| 61 |
1 |
Pan American Health Organization,
7 November 1966
|
| 61 |
2 |
Meetings - general,
1967
|
| 61 |
3-4 |
Human Vaccines - Possible Oncogenic Implications,
9 January 1967
|
| 61 |
5 |
Laboratory Methods in the Isolation and Identification of Respiroviruses and Enteroviruses,
3-4 July 1967
|
| 61 |
6 |
Respiratory Syncytial Virus Workshop,
10 July 1967
|
| 61 |
7 |
Conference on Measles Virus, etc.,
13 September 1967
|
| 61 |
8 |
Scientific Group on Respiratory Viruses,
9-14 October 1967
|
| 61 |
9 |
American Academy of Pediatrics,
25 October 1967
|
| 61 |
10 |
Symposium honoring Dr. M. D. Eaton,
1 December 1966
|
| 61 |
11 |
Meetings - general,
1968
|
| 61 |
12 |
Clinical at the College of Physicians and Surgeons, Columbia, University,
27 January 1968
|
| 61 |
13-14 |
Gustav Stern Symposium on Perspectives in Virology,
29 January 1968
|
| 61 |
15 |
American Academy of Allergy,
5-7 February 1968
|
| 61 |
16 |
American Epidemiological Society,
29-30 March 1968
|
| 61 |
17 |
American Medical Association,
23-24 April 1968
|
| 61 |
18 |
American Society for Clinical Investigation,
5 May 1968
|
| 61 |
19 |
Society for Epidemiological Research,
10-11 May 1968
|
| 61 |
20 |
Postgraduate Workshop, University of Maryland,
2 June 1968
|
| 61 |
21 |
Third International Symposium on Aerobiology,
15-19 September 1968
|
| 61 |
22 |
Influenza Genetics,
11-12 November 1968
|
| 61 |
23 |
Armed Forces Epidemiological Board Committee on Influenza,
18-20 November 1968
|
| 61 |
24 |
Twelfth International Congress of Pediatrics,
1-7 December 1968
|
| 61 |
25 |
Meetings - general,
1969
|
| 61 |
26 |
Vaccine Development Committee meeting,
27-28 January 1969
|
| 61 |
27 |
International Conference on Rubella Immunizations,
18-20 February 1969
|
| 61 |
28 |
Conference on Immunology,
2 April 1969
|
| 61 |
29-30 |
World Health Organization Virus Reference Centres meeting,
22-25 April 1969
|
| 61 |
31 |
American Society for Microbiology,
4-9 May 1969
|
| 61 |
32 |
American Society for Clinical Investigation,
5 May 1969
|
| 61 |
33 |
American Thoracic Society,
24-26 May 1969
|
| 61 |
34 |
Gustav Stern meeting,
25-26 May 1969
|
| 61 |
35 |
Ad hoc Conference on Australia Antigen and Hepatitis,
23-24 June 1969
|
| 61 |
36 |
Vaccine Development Workshop on Vaccine Testings,
27 June 1969
|
| 61 |
37 |
Virus Diseases of the Respiratory Tract,
23 September 1969
|
| 61 |
38 |
International Working Conference on Influenza,
14-16 October 1969
|
| 61 |
39 |
Infectious Disease Society of America,
25-26 October 1969
|
| 61 |
40 |
International Conference on Vaccines against Viral and Rickettsial Diseases of Man,
7-11 November 1969
|
| 61 |
41 |
Committee on Influenza,
17-19 November 1969
|
| 61 |
42 |
NICHD Immunology Workshop,
11-13 December 1969
|
| 61 |
43 |
Secretory Antibody,
10-13 December 1969
|
| 61 |
44 |
Human Responses to Viral Antigens,
3 August 1971
|
| 61 |
45 |
Mycoplasma and Mycoplasma-like Agents of Animal and Plant Diseases,
8-10 January 1973
|
| 61 |
46 |
Influenza Workshop IV,
24 January 1973
|
| 61 |
47 |
Acute Respiratory Diseases,
8-9 March 1973
|
| 61 |
48 |
Influenza Vaccines, University of Maryland,
13 March 1973
|
| 61 |
49 |
Fogarty Center Conferences on Preventive Medicine,
15-16 March 1973
|
| 61 |
50 |
ICN/UCLA Symposium on Molecular Biology-Virus Research,
18-23 March 1973
|
| 61 |
51 |
New Approaches for Inducing Natural Immunity to Pyogenic Organisms,
20-23 March 1973
|
| 61 |
52 |
Influenza Workshop V on Influenza Vaccines,
3-4, 14 April 1973
|
| 62 |
1 |
Influenza Workshop V on Influenza Vaccines (cont'd),
3-4, 14 April 1973
|
| 62 |
2 |
American Epidemiological Society,
6-7 April 1973
|
| 62 |
3 |
Epidemic Intelligence Service Conference,
9-13 April 1973
|
| 62 |
4-5 |
Directors of World Health Organization Reference Centers,
16-19 April 1973
|
| 62 |
6 |
U.S.-Japan Program,
23-27 July 1973
|
| 62 |
7-8 |
Problems of Bacteriophage Contamination,
1 August 1973
|
| 62 |
9 |
FIC Subcommittee on Infectious Diseases,
14-16 September 1973
|
| 62 |
10 |
Infectious Diseases Society of America,
17-18 September 1973
|
| 62 |
11 |
Parainfluenza and RS Candidate Vaccines,
5 October 1973
|
| 62 |
12 |
Animal Influenza and its Significance for Human Infections,
11-12 October 1973
|
| 62 |
13 |
University of Chicago Alumni Banquet,
23 October 1973
|
| 62 |
14 |
National Academy of Sciences,
23 October 1973
|
| 62 |
15 |
Interagency Meeting on Influenza,
19 November 1973
|
| 62 |
16-17 |
World Health Organization,
1-5 September 1975
|
| 62 |
18 |
Joint Working Conference of the Virus Cancer Program,
3-5 November 1975
|
| 62 |
19 |
Influenza meeting, NIH,
12 January 1976
|
| 62 |
20 |
Influenza Program Review meeting, NIH,
15-16 January 1976
|
| 62 |
21 |
Working Group on Pandemic Influenza,
26-28 January 1976
|
| 62 |
22 |
Bacterial and Viral Gastroenteritis,
5-6 February 1976
|
| 62 |
23 |
Bureau of Biologics,
20 February 1976
|
| 62 |
24 |
Walter Reed Ad Hoc meeting,
8 March 1976
|
| 62 |
25 |
Armed Forces Epidemiological Board,
12 March 1976
|
| 62 |
26 |
Bureau of Biologics,
25 March 1976
|
| 62 |
27 |
Current Status and Prospect for Improved and New Bacterial Vaccines,
29 March-1 April 1976
|
| 62 |
28 |
Influenza meeting, NIH,
15 April 1976
|
| 62 |
29 |
National Academy of Sciences,
26-28 April 1976
|
| 62 |
30 |
American Epidemiological Society,
29 April-1 May 1976
|
| 62 |
31 |
Association of American Physicians,
30 April-2 May 1976
|
| 62 |
32 |
American Society for Microbiology,
2-7 May 1976
|
| 62 |
33 |
Association of American Physicians,
4 May 1976
|
| 62 |
34 |
Conference on Persistent Viral Infections,
13-16 June 1976
|
| 62 |
35 |
Bureau of Biologics,
21-22 June 1976
|
| 62 |
36 |
Bronchiolitis workshop,
28-29 June 1976
|
| 62 |
37 |
Festschrift for Albert Sabin,
26 August 1976
|
| 62 |
38 |
Consensus Development on Use of Amantadine,
15-16 October 1976
|
| 62 |
39 |
Infectious Disease Society of America,
25-26 October 1976
|
| 62 |
40 |
Ad Hoc Viral and Rickettsial Disease Study Group,
8 November 1976
|
| 62 |
41 |
Viral and Bacterial Vaccines, Present Knowledge and Future Development International Symposium,
7-8 September 1977
|
| 62 |
42 |
Chinese delegation,
1979
|
| 62 |
43 |
Experimental Herpesvirus Vaccine workshop,
7-9 February 1979
|
| 62 |
44 |
Surgeon General's Meeting on Influenza,
12 February 1979
|
| 62 |
45 |
Medical Research Council,
20 February 1979
|
| 62 |
46 |
Symposium on Potentiation of Immune Response to Vaccines,
20-21 February 1979
|
| 62 |
47 |
The Royal Society Meeting on Influenza,
21-22 February 1979
|
| 63 |
1 |
Secretary's Conference on Influenza,
6 March 1979
|
| 63 |
2 |
Attenuated Influenza Vaccine workshop, NIH,
9 March 1979
|
| 63 |
3 |
American Physicians Fellowship Program, NIH,
29-30 March 1979
|
| 63 |
4 |
American Epidemiological Society,
30-31 March 1979
|
| 63 |
5 |
Vaccine Studies in the Elderly,
30 April 1979
|
| 63 |
6 |
American Society for Microbiology,
4-11 May 1979
|
| 63 |
7 |
Influenza B Viruses workshop,
30-31, 1979
|
| 63 |
8 |
Prevention of Major Infectious Diseases: Current Concerns and Future Promise,
20-21 September 1979
|
| 63 |
9 |
Medical Society of the District of Columbia,
27-28 September 1979
|
| 63 |
10 |
Infectious Diseases Society of America,
5-6 October 1979
|
| 63 |
11 |
Molecular Approaches to Vaccine Development,
10 October 1979
|
| 63 |
12 |
U.S.-U.S.S.R. Influenza meeting,
16-18 October 1979
|
| 63 |
13 |
Genetic Variation of Viruses,
28-30 November 1979
|
| 63 |
14 |
Australian Commonwealth Scientific and Industrial Research Organization,
10-12 December 1979
|
| 63 |
15 |
Perspectives in Virology,
4-5 February 1980
|
| 63 |
16 |
Australian Academy of Science,
8-12 February 1982
|
| 63 |
17 |
Duke University seminar,
4 February 1980
|
| 63 |
18 |
Attenuated Vaccines,
10 March 1980
|
| 63 |
19 |
Pritzker School of Medicine Council meeting,
2 May 1980
|
| 63 |
20 |
American Society for Microbiology,
11-16 May 1980
|
| 63 |
21 |
Eradication of Infectious Diseases,
27-28 May 1980
|
| 63 |
22 |
Infectious Disease Society of America,
25-26 September 1980
|
| 63 |
23 |
Negative Strand Viruses,
27 October-1 November 1980
|
| 63 |
24 |
World Health Organization Consultation on Influenza,
5-6 November 1980
|
| 63 |
25 |
Department of Microbiology and Molecular Genetics seminar,
2 December 1980
|
| 63 |
26 |
ICN/UCLA Symposium on Genetic Variation of Influenza Viruses,
8-13 March 1981
|
| 63 |
27 |
International Symposium on Viral Hepatitis,
30 March-2 April 1981
|
| 63 |
28 |
Department of Microbiology and Immunology seminar, Duke University,
16 April 1981
|
| 63 |
29 |
Mt. Sinai Symposium on Infections Caused by Enteric Viruses,
4 June 1981
|
| 63 |
30 |
International Congress of Virology,
2-7 August 1981
|
| 63 |
31 |
Respiratory Diseases meeting,
16 October 1981
|
| 63 |
32 |
Workshop on Respiratory Diseases,
21-22 June 1982
|
| 63 |
33 |
International Symposium on Polilomyelitis Control,
14-17 March 1983
|
| 63 |
34 |
NIAID Workshop on AIDS,
5-6 April 1983
|
| 63 |
35 |
Towards New Vaccines Against Virus Infections,
21-23 June 1983
|
| 63 |
36 |
London Conference on Influenza,
21-23 September 1983
|
| 63 |
37 |
Association of American Physicians,
29 April-2 May 1983
|
| 63 |
38-47 |
Modern Approaches to Vaccine,
31 August-4 September 1983
|
| 63 |
48 |
Negative Strand Virus meeting,
11-17 September 1983
|
| 63 |
49 |
International Conference on Immunobiology and Prophylaxis of Human Herpesvirus Infections,
9-12 October 1983
|
| 63 |
50 |
19th Immunization Conference - proceedings,
21-24 May 1984
|
| 63 |
51 |
International Congress of Virology,
1-7 September 1984
|
| 63 |
52 |
International Workshop on the Molecular Biology of Flaviviruses,
29 November-1 December 1984
|
| 63 |
53 |
Status of Attenuated Influenza Vaccines,
10-11 December 1984
|
| 63 |
54 |
Rowe Symposium,
11-12 February 1985
|
| 63 |
55 |
Rotavirus Vaccine Work Group,
13 March 1985
|
| 63 |
56 |
Genetically Altered Viruses,
28 April-1 May 1985
|
| 64 |
1 |
American Society for Virology,
21-25 July 1985
|
| 64 |
2 |
World Health Organization Steering Committee on Acute Respiratory Viruses,
29-30 July 1985
|
| 64 |
3-5 |
Modern Approaches to Vaccines,
11-15 September 1985
|
| 64 |
6 |
The Biology of Negative Strand Viruses,
15-20 September 1985
|
| 64 |
7 |
Expression of Foreign Genes,
4-7 October 1985
|
| 64 |
8 |
RSV Symposium,
16 October 1985
|
| 64 |
9 |
Duke University Academic Visiting Professor,
16-18 December 1985
|
| 64 |
10 |
Scripps Scientific Review Committee,
13-15 January 1986
|
| 64 |
11 |
Rowe Symposium,
3-4 February 1986
|
| 64 |
12 |
Vaccinia-Vectoring,
31 March 1986
|
| 64 |
13 |
Cosmos Club award, Albert Sabin,
15 April 1986
|
| 64 |
14 |
Vaccine Supply and Innovation workshop,
24-25 April 1986
|
| 64 |
15 |
Association of American Physicians,
2-4 Mary 1986
|
| 64 |
16 |
Influenza Viruses,
20 May 1986
|
| 64 |
17 |
World Health Organization Acute Respiratory Viruses meeting,
27-28 June 1986
|
| 64 |
18 |
FEBS meeting,
24-29 August 1986
|
| 64 |
19 |
Infectious Diseases Society of America,
2-3 October 1986
|
| 64 |
20 |
Scripps Scientific Review Committee,
10 January 1987
|
| 64 |
21 |
Rowe Symposium,
2-3 February 1987
|
| 64 |
22 |
AIDS Vaccines workshop,
25-27 March 1987
|
| 64 |
23 |
Workshop on Respiratory Syncytial and Parainfluenza Viruses,
4-5 May 1987
|
| 64 |
24 |
Scholars-in-Residence symposium,
11-14 May 1987
|
| 64 |
25 |
Pasteur Centenary Symposium,
26-28 May 1987
|
| 64 |
26 |
American Society for Virology,
31 May-4 June 1987
|
| 64 |
27 |
International Conference on AIDS,
1-5 June 1987
|
| 64 |
28-29 |
Nobel Symposium on the Vaccines of the Future,
23-26 August 1987
|
| 64 |
30 |
International Symposium on Infectious Diseases,
11-12 November 1987
|
| 64 |
31 |
Live Viral Vaccines for Respiratory and Enteric Tract Diseases,
24 November 1987
|
| 64 |
32 |
Conference on the Development of Vaccines Against HIV and AIDS,
14-15 December 1987
|
| 64 |
33 |
Scripps Scientific Review Committee,
14 January 1988
|
| 64 |
34 |
Conference on Poliomyelitis Vaccines: Re-evaluating Policy Options,
21-22 January 1988
|
| 64 |
35 |
Rowe Symposium,
1-2 February 1988
|
| 64 |
36 |
National Academy of Sciences Committee on International Security and Arms Control,
16 March 1988
|
| 64 |
37 |
Oral Immunization symposium,
21-22 March 1988
|
| 64 |
38 |
NIH Seminar,
6 April 1988
|
| 64 |
39 |
American Pediatric Society Centennial Celebration,
3 May 1988
|
| 64 |
40 |
National Academy of Sciences and Academy of Sciences of the USSR on Biological Weapons,
9-11 May 1988
|
| 64 |
41 |
Wagner Symposium,
15-16 May 1988
|
| 64 |
42 |
Live Attenuated Influenza Virus Vaccine,
26 May 1988
|
| 64 |
43 |
American Society for Virology,
12-16 June 1988
|
| 64 |
44 |
NIH Rotavirus Vaccine workshop,
8-9 September 1988
|
| 64 |
45 |
Modern Approaches to New Vaccines Including Prevention of AIDS,
14-18 September 1988
|
| 64 |
46 |
Immunology of Virus Diseases,
26-28 October 1988
|
| 64 |
47 |
Genetic Basis of Human Disease,
30 November-1 December 1988
|
| 64 |
48 |
Institute of Medicine Research Briefing Panel,
27-28 April 1989
|
| 64 |
49 |
Symposium on Respiratory Virus Vaccine Development,
1 May 1989
|
| 64 |
50 |
American Society for Virology,
9-13 July 1989
|
| 64 |
51-52 |
Modern Approaches to New Vaccines Including Prevention of AIDS,
20-24 September 1989
|
| 64 |
53 |
International Conference on Comparative and Applied Virology,
15-21 October 1989
|
| 64 |
54 |
Rowe Symposium,
5-6 February 1989
|
| 64 |
55-56 |
American Thoracic Society,
23 May 1990
|
| 65 |
1 |
American Thoracic Society (cont'd),
23 May 1990
|
| 65 |
2 |
International Congress of Virology,
26-31 August 1990
|
| 65 |
3 |
Children's Vaccine Initiative,
6 August 1990
|
| 65 |
4 |
Colloquium on Human Diseases - Molecular Mechanisms of Viral Pathogenesis,
19-20 October 1990
|
| 65 |
5 |
Animal Models of Respiratory Syncytial Virus Infections,
24-25 October 1990
|
| 65 |
6 |
NIH Rotavirus Vaccine Workshop,
5-6 November 1990
|
| 65 |
7 |
Rowe Symposium,
4-5 February 1991
|
| 65 |
8 |
Saul Krugman Festschrift,
12 April 1991
|
| 65 |
9 |
Inauguration of Richard M. Haidack Distinguished Professorship in Medicine,
29 May 1991
|
| 65 |
10 |
Pathogenesis Symposium,
5 December 1991
|
| 65 |
11 |
Rowe Symposium,
3-4 February 1992
|
| 65 |
12 |
NIAID Interdivisional AIDS Working Group,
24 April 1992
|
| 65 |
13 |
Measles workshop,
14-15 September 1992
|
| 65 |
14 |
Lounsbury Award Jury Dinner,
5 November 1992
|
| 65 |
15 |
Innovations in Therapy of Human Viral Diseases,
6-7 December 1992
|
| 65 |
16 |
Molecular Pathogenesis of Infections and Tumors,
5-6 May 1994
|
| 65 |
17 |
Scientific Symposium to Honor the Work of Janet W. Hartley,
13 September 1994
|
| 65 |
18 |
Scientific Meeting of the Australian Society for Microbiology,
26-30 September 1994
|
| 65 |
19 |
Molecular Approaches to the Control of Infectious Diseases,
5-9 October 1994
|
| 65 |
20-21 |
Frank and Bobbie Fenner Conference in Medical Research,
28-30 November 1994
|
| 65 |
22 |
Office of Science and Technology Policy meeting,
29 March 1995
|
| 65 |
23 |
Fogarty Advisory Board,
23 May 1995
|
| 65 |
24 |
Igor Tamm Memorial Symposium,
30 November 1995
|
| 65 |
25 |
Thomas Merigan Lecture,
23-29 May 1996
|
| 65 |
26 |
Conference on Immunoglobulins,
2-4 June 1996
|
| 65 |
27 |
Antibody workshop,
2-4 June 1996
|
| 65 |
28 |
Simian Virus 40 workshop,
27-28 January 1997
|
| 65 |
29-30 |
NIAID Principal Investigators' retreat,
20-21 November 1997
|
| 65 |
31 |
Center for Biologics Evaluation and Research, Vaccines and Related Biological Products Advisory Committee,
19-20 Novebmer 1998
|
| 65 |
32 |
American Epidemiological Society,
18-19 March 1999
|
| 65 |
33 |
Memorial Symposium for Robert Huebner,
11 November 1999
|
| 65 |
34 |
Conference on Vaccine Research,
1-2 May 2000
|
| 65 |
35 |
NIAID Principal Investigators' workshop,
6-7 November 2000
|
| 65 |
36 |
NIAID Principal Investigators' workshop,
14-15 November 2002
|
| 65 |
37 |
RSV 2003 Symposium,
8-11 November 2003
|
| 65 |
38 |
Trans-NIH/FDA Intramural Biodefense Symposium,
7-8 April 2004
|
| 65 |
39 |
Rotavirus Symposium,
7-9 July 2005
|
| 65 |
40 |
RSV Symposium,
15-18 September 2005
|
| |
Series 7: Lectures and Speeches,
1951-2005 [series]:
|
| 65 |
41 |
Control of pediatric viral diseases: past successes and future prospects,
undated
|
| 65 |
42 |
Untitled ["There seems little reason to doubt that antibody in serum is an important mediator"],
c.1950s
|
| 65 |
43 |
Hemagluttination with the virus of western equine encephalitis - with Sabin,
30 November 1951
|
| 65 |
44 |
Hemagglutinins of St. Louis and western equine viruses - isolation, properties, and use for diagnosis and epidemiologic survey,
5 May 1952
|
| 65 |
45 |
The Hemagglutination test for Japanese encephalitis, a diagnosis and survey tool,
1955
|
| 65 |
46 |
Untitled ["I'd like to start off by describing in some detail, of course I'll probably be offending some, viruses and some of the tests we use in"],
25 November 1958
|
| 65 |
47 |
Mycoplasma pneumoniae infections - prospects for live and inactivated vaccines,
c.1963
|
| 65 |
48 |
Infections caused by mycoplasmas,
4 November 1965
|
| 65 |
49 |
Australia antigen and serum hepatitis,
1970
|
| 65 |
50 |
Untitled [at International Congress of Microbiology],
August 1970
|
| 65 |
51 |
Parainfluenza virus epidemiology,
3 May 1974
|
| 65 |
52 |
Untitled ["For approximately the past five years the Laboratory of Infectious Diseases at the NIH in Bethesda has been involved in the study of acute infectious nonbacterial gastroenteritis."],
September 1975
|
| 65 |
53 |
Untitled ["This morning I would like to discuss two areas of study in which we have been involved concerning human reovirus-like agent of infantile gastroenteritis.",
1976
|
| 65 |
54 |
Chicago talk,
1977
|
| 65 |
55 |
R. E. Dyer lecture,
30 May 1978
|
| 65 |
56 |
Medicine for Laymen series lecture,
4 December 1979
|
| 65 |
57 |
Smadel lecture at Infectious Diseases Society meeting,
26 September 1980
|
| 65 |
58 |
Saz Immunology Lecture,
9 October 1985
|
| 65 |
59 |
Successful strategy for selection and characterization of live poliomyelitis virus vaccine strains,
27 October 1986
|
| 66 |
1 |
Feldman Memorial Lecture,
17-18 March 1987
|
| 66 |
2 |
FAES lecture,
7 December 1988
|
| 66 |
3-4 |
Talamo lecture,
4 April 1990
|
| 66 |
5 |
Children's Hospital National Medical Center,
22 October 1990
|
| 66 |
6 |
Respiratory syncytial virus: thirty-five year status report on research achievements, opportunities and frustrations,
7 February 1991
|
| 66 |
7 |
Careers in virology: a good beginning is usually required for a good ending,
7 or 12 February 1991
|
| 66 |
8 |
Albert Sabin eulogy,
1993
|
| 66 |
9 |
Natural history of RSV,
1994
|
| 66 |
10-11 |
Sabin Lecture, Cold Spring Harbor,
September 1995
|
| 66 |
12 |
Untitled ["sabin.doc"],
1997
|
| 66 |
13 |
Huebner Symposium lecture,
10 November 1999
|
| 66 |
14 |
Speech in honor of Brian Murphy,
2003
|
| 66 |
15 |
R. Walter Schlesinger, M.D. (1913-2003),
5 November 2003
|
| 66 |
16 |
Tribute to Albertk Kapikian, honored with Albert Sabin Foundation Gold Medal,
16 May 2005
|
| |
Series 8: Videocassettes,
1985-1987 [series]:
|
| 67 |
|
Wallace P. Rowe Symposium [11 Umatic videocassettes],
12 February 1985
|
| 68 |
|
A Scientific Symposium in Honor of Albert B. Sabin's 80th Birthday [9 Umatic, 5 vhs videocassettes],
26 August 1986
|
| 68 |
|
Bldg10/ACRF [1 Umatic videocassette],
11 May 1987
|
|
